Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
254
Chapter.8
Bibliography
255
A
Abuja PM, Albertini R. Methods for monitoring oxidative stress, lipid peroxidation and
oxidation resistance of lipoproteins. Clin Chim Acta 2001;360:1-17.
Abul-Ezz SR, Walker PD, Shah SV. Role of glutathione in an animal model of
myoglobinuric acute renal failure. Proc Natl Acad Sci U S A 1991;88:9833-9837.
Ackermann D, Heinsen HA. Uber die physiologische Wirkung des Asterubins und anderer,
zum Teil neu dargestellter, schwefelhaltiger Guanidinderivate. Hoppe Seyles Z Physiol
Chemie 1935; 235: 115–121.
Aebi H. Catalase in vitro, Methods Enzymol 1984;105:121– 126.
Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF. Phosphorylation of
Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and
inhibits insulin action. J Biol Chem 2002;277:1531-1537.
Alexandraki K, Piperi C, Kalofoutis C, Singh J, Alaveras A, Kalofoutis A. Inflammatory
process in type 2 diabetes: the role of cytokines. Ann NY Acad Sci 2006; 1084:89-117.
Allen DW, Schroeder WA, Balog J. Observations on the chromatographic heterogeneity of
normal adult and fetal human hemoglobin. J Am Chem Soc 1958;80:1628– 34.
Alvestrand A, Majagic M, Wajngot A, Efendic S. Glucose intolerance in uremic patients: The
relative contributions of impaired β-cell function and insulin resistance. Clin Nephro
1989;31:175-183.
Alvestrand A. Carbohydrate and insulin metabolism in renal failure. Kidney Int 1997;62:S48-
S52.
Amann K, Koch A, Hofstetter J, Gross ML, Haas C, Orth SR, Elmke H, Rump LC, Ritz E.
Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta
blockers. Kidney Int 2001;60:1309-1323.
Ames DNA damage from micronutrient deficiencies is likely to be a major cause of cancer.
Mutat Res 2001;475:7-20.
Anderson RA, Polansky MM. Tea enhances insulin activity. J Agric Food Chem
2002;50:7182-7186.
Annuk M, Zilmer M, Lind L, Linde T, Fellstrom B. Oxidative stress and endothelial function
in chronic renal failure. J Am Soc Nephrol 2001;12:2747–2752.
Annukk M, Zilmer M, Fellstrom B. Endotehlium-dependent vasodilation and oxidative stress
in chronic renal failure: Impact on cardiovascular disease. Kidney Int Suppl 2003;84:50-53.
256
Anuradha CV, Balakrishnan SD. Taurine attenuates hypertension and improves insulin
sensitivity in the fructose-fed rat, an animal model of insulin resistance. Can J Physiol
Pharmacol 1999; 77: 749–754.
Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-
reactive protein the missing link? Kidney Int 2001;59:407–414.
Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G,
Olefsky J, Karin M.. IKK-beta links inflammation to obesity-induced insulin resistance. Nat
Med 2005;11:191-198.
Aronis A, Madar Z, Tirosh O. Mechanism underlying oxidative stress-mediated lipotoxicity:
Exposure of j774.2 macrophages to triacylglycerols facilitates mitochondrial reactive oxygen
species production and cellular necrosis. Free Radic. Biol. Med. 2005;38:1221–1230.
Arguelles S, Garcia S, Maldonado M, Machado A, Ayala A. Do the serum oxidative stress
biomarkers provide a reasonable index of the general oxidative stress status? Biochim
Bipphys Acta 2004;1674:251-259.
Arsie MP, Marchioro L, Lapolla A. Evaluation of diagnostic reliability of DCA 2000 for
rapid and simple monitoring of HbA1C. Acta Diabetol 2000;37:1– 7.
Asante-Appiah E, Kennedy BP. Protein tyrosine phosphatases: the quest for negative
regulators of insulin action. Am J Physiol Endocrinol Metab 2003;284:E663-670.
Aso Y. Cardiovascular disease in patients with diabetic nephropathy. Curr Mol Med. 2008;
8:533-43.
Auroma OI, Halliwell B, Hoey BM, Butler J. Antioxidant action of taurine, hypotaurine and
their metabolic precursors. Biochem J 1988;256:251-255.
Auroma OI, Halliwell B, Gajewski E, Dizdaroglu M. Copper-iron dependent damage to bases
in DNA in the presence of hydrogen peroxide. Biochem J 1991;273:2601-2604.
Axelsson J, Qureshi AR, Sulinan ME. Truncal fat mass as a contributor to inflammation in
end-stage renal disease. Am J Clin Nutr 2004;80:1222–1229.
B
Babu NP, Bobby Z, Selvaraj N, Harish BN. Increased fructosamine in non-diabetic
rheumatoid arthritis patients: role of lipid peroxides and glutathione. Clin Chem Lab Med
2006;44:848-852.
257
Bak JF, Schmitz O, Sørensen SS. Activity of insulin receptor kinase and glycogen synthase in
skeletal muscle from patients with chronic renal failure. Acta Endocrinol (Copenh)
1989;121:744-750.
Balamurugan R, Bobby Z, Selvaraj N, Nalini P, Koner BC, Sen SK. Increased protein
glycation in non-diabetic pediatric nephritic syndrome: possible role of lipid peroxidation.
Clin Chim Acta 2003;337:127-132.
Balamurugan R, Selvaraj N, Bobby Z, Sathiyapriya V. Increased glycated hemoglobin level
in non-diabetic nephrotic children is associated with oxidative stress. Indian J Physiol
Parmacol 2007;51:153-159.
Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM. Increased p85/55/50 expression and
decreased phopshatidylinositol 3-kinase activity in insulin-resistance human skeletal muscle.
Diabetes 2005;54:2351-2539.
Barazzoni R, Biolo G, Zanetti M, Bernardi A, Guarnieri G. Inflammation and adipose tissue
in uremia. J Ren Nutr 2006;16:204-207.
Barford D, Jia Z, Tonks NK. Protein tyrosine phosphatases take off. Nat Struct Biol.
1995;2:1043–1053.
Barnes PJ, Karin M. Nuclear factor κB - a pivotal transcription factor in chronic
inflammatory disease. N Engl J Med 1997;336:1066–1071.
Barrett WC, DeGnore JP, Keng YF, Zhang ZY, Yim MB, Chock PB. Roles of superoxide
radical anion in signal transduction mediated by reversible regulation of protein-tyrosine
phosphatase 1B. J Biol Chem 1999;274:34543–34546.
Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL,
Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O'Rahilly S. Dominant negative
mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus
and hypertension. Nature 1999;402:880–3.
Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J,
Hainque B. Adipose tissue IL-6 content correlates with resistance to insulin activation of
glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002;87:2084-9.
Basu S, Kolesnick R. Stress signals for apoptosis: ceramide and c-Jun kinase. Oncogene
1998;17: 3277–3285.
Baumann H, Gauldie J. The acute phase response. Immunol Today 1994;15:74–80.
Baynes JW. Role of oxidative stress in development of complications of diabetes. Diabetes
1991;40:405–412.
258
Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective
on an old paradigm. Diabetes 1999;48:1– 9.
Beckman JS. Ischemic injury mediator. Nature (Lond.) 1990;345:27–28.
Bemelmans MH, Gouma DJ, Buurmanwa. Influence of nephrectomy on tumor necrosis factor
clearance in murine model. J Immunol 1993;150:2007–2017.
Bender K, Gottlicher M, Whiteside S, Rahmsdorf HJ, Herrlich P. Sequential DNA damage-
independent and –dependent activation of NF-kappaB by UV. EMBO J 1998;17:5170–5181.
Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocytes-secreted protein
Acrp30 enhances hepatic insulin action. Nat Med 2001;7:947-953.
Bergström J, Hultman E. Glycogen content of skeletal muscle in patients with renal failure.
Acta Med Scand 1969;186:989-998.
Benjamin R, Sacks D. Glycated protein update: implications of recent studies, including the
diabetes control and complications trial. Clin Chem 1994;40:683-687.
Besarab A, Levin A. Defining a renal anemia management period. Am J Kidney Dis Suppl
2000;36:S13-S23.
Bertani T, Abbate M, Zoja C, et al. Tumor necrosis factor induces glomerular damage in the
rabbit. Am J Pathol 1989;134:419–430.
Beutler E, Kelley BM. The effect of sodium nitrate on RBC glutathione. Experientia
1963;19:96-97.
Bevan P. Insulin signalling. J Cell Sci 2001;114:1429–30.
Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in
human veins in vivo. Circulation 1997;96:3042–3047.
Birdsall TC. Therapeutical application of taurine. Altern Med Rev 1998;3:128-136.
Birnbaum MJ. Turning down insulin signalling. J Clin Invest 2001;108:655-659.
Blair AS, Hajduch E, Litherland GJ, Hundal HS. Regulation of glucose transport and
glycogen synthesis fin L6 muscle cells during oxidative stress. Evidence for cross-talk
between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways. J
Biol Chem 1999;274:36293–36299.
Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y,
Brooks AP, Metcalfe J, Day JL, Edwards MS. Iron deficiency and glycosylated haemoglobin
A1. Lancet 1980;19. ii:141.
Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y,
Brunner D, Fainaru M, Green MS. Secondary prevention with antioxidants of cardiovascular
259
disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet.
2000;356:1213-8.
Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL. Interleukin-
6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients.
Am J Kidney Dis 1998;32:107–114.
Bolton CH, Downs LG, Victory JGG, Dwight JF, Tomson CR, Mackness MI, Pinkney JH.
Endothelial dysfunction in chronic renal failure: Roles of lipoprotein oxidation and pro-
inflammatory cytokines. Nephrol Dial Transplant 2001;16:1189–1197.
Bone RC. Immunologic dissonance: A continuing evolution in our understanding of the
systemic inflammatory response syndrome and the multiple organ dysfunction syndrome.
Ann Intern Med 1996;125:690–691.
Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/- mice
reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998;394:894–897.
Boveris A, Costa LE, Cadenas E, Poderoso JJ. Regulation of mitochondrial respiration by
adenosine diphosphate, oxygen and nitric oxide. Methods Enzymol 1999;301:188–198.
Bradford M. A rapid and sensitive method for the quantification of microgram quantity of
protein utilizing the principle of protein dye binding. Anal Biochem 1976;72: 248-254.
Brand K, Page S, Walli AK, Neumeier D, Baeuerle PA. Role of nuclear factor-kappa B in
atherogenesis. Exp Physiol 1997;82:297–304.
Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: a hard Akt to follow.
Trends Biochem Sci 2001;26:657–64.
Brenner RR. Endocrine control of fatty acid desaturation. Biochem Soc Trans 1990;18:773–
775.
Brett J, Schmidt AM, Yan SD, Zou YS, Weidman E, Pinsky D, Nowygrod R, Neeper M,
Przysiecki C, Shaw A. Survey of the distribution of a newly characterized receptor for
advanced glycation end products in tissues. Am J Pathol. 1993;143:1699-712.
Broadhurst CL, Polansdy MM, Anderson RA. Insulin-like biological activity of culinary and
medicinal plant aqueous extracts in vitro. J Agric Food Chem 2000;48:849-852.
Brown GC. Nitric oxide and mitochondrial respiration. Biochim Biophys Acta
1999;1411:351–369.
Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products and the
biochemical basis of diabetic complications. N Engl J Med 1988;318:1315– 21.
Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes
2005;54:1615–1625.
260
Brunner D, Fainaru M, Green MS. Secondary prevention with antioxidants of cardiovascular
disease in end-stage disease (SPACE): randomised placebo- controlled trial. Lancet
2000;356: 1213-1218.
Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, Richelsen B. Regulation
of adiponectin by tissue-derived cytokines; in vivo and in vitro investigations in humans. Am
J Physiol Endocrinol Metab 2003; 285:E527–E533.
Bui NT, Livolsi A, Peyron JF, Prehn JH. Activation of nuclear factor kappaB and Bcl-x
survival gene expression by nerve growth factor requires tyrosine phosphorylation of
IkappaB alpha. J Cell Biol 2001;152:753–764.
Buren J, Lindmark S, Renstrom F, Eriksson JW. In vitro reversal of hyperglycemia
normalizes insulin action in fat cells from type 2 diabetes patients: Is cellular insulin
resistance caused by glucotoxicity in vivo? Metabolism 2003;52:239–245.
C Caglar K, Peng Y, Pupim LB, Flakoll PJ, Levenhagen D, Hakim RM, Ikizler TA.
Inflammatory signals associated with hemodialysis. Kidney Int 2002;62:1408–1416.
Canaud B, Chenine L, Leray-Moragues H, Wiesen H, Tetta C. Residual renal function and
dialysis modality: Is it really beneficial to preserve residual renal function in dialysis
modality: Is it really beneficial to preserve residual renal function in dialysis patients?
Nephrology 2006;11:292-296.
Carantoni M, Abbasi F, Warmerdam F, Klebanov M, Wang PW, Chen YDI, Azhar S, Reaven
GM. Relationship between insulin resistance and partially oxidized LDL particles in healthy,
nondiabetic volunteers. Arterioscler Thromb Vasc Biol 1998;18:762–767.
Carvalho CR, Brenelli SL, Silva AC, Nunes AL, Velloso LA, Saad MJ. Effect of aging on
insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and
muscle of rats. Endocrinology 1996;137:151-9.
Casparie AF, Miedema K. GLycosylated hemoglobin in diabetes and renal failure. Lancet
1977;2:1833-1835.
Castellino P, AS, Luzi L, Barr JG, Smith DJ, Petrides A, Giordano M, Carroll C, DeFronzo
RA. Glucose and amino acid metabolism in chronic renal failure: Effect of insulin and amino
acids. Am J Physiol 1992;262:F168-F176.
261
Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, Nguyen AT, Thevenin M, Jaudon MC,
Zingraff J, Verger C, Jungers P, Descamps-Latscha B. Glutathione antioxidant system as a
marker of oxidative stress in chronic renal failure. Free Rad Biol Med 1996;21:845–853.
Cecchin E, De Marchi S, Panarello G, De Angelis V. Rheological abnormalities of
erythrocyte deformability and increased glycosylation of hemoglobin in nephrotic syndrome.
Am J Nephrol 1987;7:18-21.
Cefalu WT, Wang ZQ, Bell-farrow A, Ralapati S. Liver and kidney tissue membranes as
tissue markers for nonenzymatic glycosylation. Diabetes 1991;40:902– 7.
Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ. Vitamin E
reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic
complications? Diabetes Care 1991;14:68-72.
Ceriello A. Is oxidative stress the missing link between insulin resistance and atherosclerosis?
Diabetologia 1995; 38:1484–1485.
Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000;49:27–29.
Chade AR, Rodriguez-Porcel M, Grande JP. Krier JD, Lerman A, Romero JC, Napoli C,
Lerman LO. Distinct renal injury in early atherosclerosis and renovascular disease.
Circulation 2002;106:1165-1171.
Chakravarthy BK, Gupta S, Gode KD. Functional beta cell regeneration in the islets of
pancreas in alloxan induced diabetic rats by (-)-epicatechin. Life Sci 1982;31:2693-2697.
Chen NG, Azhar S, Abbasi F, Carantoni M, Reaven GM. The relationship between plasma
glucose and insulin response to oral glucose, LDL oxidation, and soluble intercellular
adhesion molecule-1 in healthy volunteers. Atherosclerosis 2000;152: 203–208.
Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, He J. Insulin resistance
and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003;14:469-
477.
Chen M, Robertson RP. Restoration of the acute insulin response by sodium salicylate: a
glucose dose-related phenomenon. Diabetes 1978;27:750-756.
Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IkappaB alpha by a novel
ubiquitination-dependent protein kinase activity. Cell 1996;84:853–862.
Chen X, Scholl TO, Leskiw MJ, Donaldson MR, Stein TP. Association of glutathione
peroxidase activity with insulin resistance and dietary fat intake during normal pregnancy. J
Clin Endocrinol Metab 2003;88:5963-5968.
Cheng TO, Green tea, coffee, and diabetes. Ann Intern Med 2006;145:633-4.
262
Chowdhury TA, Lasker SS. Elevated glycated haemoglobin in nondiabetic patients is
associated with an increased mortality in myocardial infarction. Postgrad Med J 1998;74:480-
481.
Chugh SN, Jain S, Agrawal N, Sharma A. Evaluation of oxidative stress before and after
hemodialysis in chronic renal failure. J Assoc Phys India 2000;48:981– 4.
Chung HY, Yokozawa T, Soung DY, Kye IS, No JK, Baek BS. Peroxynitrite-scavenging
activity of green tea tannin. J Agric Food Chem 1998;46:4484-4486.
Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of
hemoglobin A1C in nondiabetic patients. Acta Haematol 2004;112:126-128.
Cohen MP, Wu V-Y. Identification of specific amino acids in diabetic glomerular basement
membrane collagen subject to non-enzymatic glucosylation in vivo. Biochem Biophys Res
Commun 1981;100:1549 – 54.
Cohen P. The structure and regulation of protein phosphatase. Annu Rev Biochem
1989;58:453-508.
Collins T, Cybulsky MI. NF-kappaB: pivotal mediator or innocent bystander in
atherogenesis? J Clin Invest 2001;107:255–264.
Conteras I, Caro JF, Aveledo L, Diaz K, Durrego P, Weisinger JR. In chronic uremia, insulin
activates receptor kinase but not pyruvate dehydrogenase. Nephron 1992;61:77-81.
Cybulsky MI, Gimbrone MAJ. Endothelial expression of a mononuclear leukocyte adhesion
molecule during atherogenesis. Science 1991;251:788–791.
D
D’ Alessandris C, Lauro R, Presta I, Sesti G. C-reactive protein induces phosphorylation of
insulin receptor substrate – 1 on Ser 307 and Ser 612 in L6 myocytes, thereby impairing the
insulin signalling pathway that promotes glucose transport. Diabetologia 2007;50:840-849.
Dandona P, Freedman DB, Moorhead J. Glycosylated Hb in chronic renal failure. Br Med J
1979;i:1183-1184.
Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein,
albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective
studies. JAMA 1998;279:1477-1482.
Danielski M, Ikizler TA, McMonagle E, Kane JC, Pupim L, Morrow J, Himmelfarb J.
Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving
maintenance hemodialysis therapy. Am J Kidney Dis 2003;42:286–294.
263
Davie S, Gould B, Yudkin J. Effect of vitamin C on glycosylation of proteins. Diabetes
1992;41:167-173.
Davies KJA. Protein damage and degradation by oxygen free radicals. II Modification of
amino acids. J Biol Chem 1987a;262: 9902-9907.
Davies KJA. Protein damage and degradation by oxygen free radicals. IV Degradation of
denatured proteins. J Biol Chem 1987b; 262: 9914-9920.
Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000;103:239-252.
de Alvaro C, Teruel T, Hernandez R, Lorenzo M. Tumor necrosis factor-α produces insulin
resistance in skeletal muscle by activation of inhibitor-kB Kinase in a p38 MAPK-dependent
manner. J Biol Chem 2004;279:17070-17078.
De Biase L, Pignatellii P, Lenti L, Tocci G, Piccioni F, Riondino S, Pulcinelli FM, Rubattu S,
Volpe M, Violi F. Enhanced TNF alpha and oxidative stress in patients with heart failure:
effect of TNF alpha on platelet O2− production. Thromb Haemost 2003;90:317–325.
De Boer MJ, Miedema K, Casparie AF. Glycosylated hemoglobin in renal failure.
Diabetologia 1980;18:437-440.
Decsi T, Molnár D, Koletzko B. Lipid corrected plasma α-tocopherol values are inversely
related to fasting insulinaemia in obese children. Int J Obes Relat Metab Disord 1996;20:
970–972.
DeFronzo RA, Tobin JD, Rowe JW, Andres R. Glucose intolerance in uremia: Quantification
of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest
1978;62:425-435.
DeFronzo RA, Beckles AD. Glucose intolerance following chronic metabolic acidosis in
man. Am J Physiol 1979;236:E328-E334.
DeFronzo RA, Alvestrand A. Glucose intolerance in uremia: Site and mechanism. Am J Clin
Nutr 1980;33:1438-1445.
DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in
uremia. J Clin Invest 1981;67:563-568.
del Aguila LF, Claffey KP, Kirwan JP. TNF-alpha impairs insulin signalling and insulin
stimulation of glucose uptake in C2C12 muscle cells. Am J Physiol 1999;276:E849–E855.
De Marchi S, Cecchin E, Basile A, Donadon W, Lippi U, Quaia P, Tesio F. More on the
increase of hemoglobin A1 in chronic renal failure: the role of acidosis. Nephron 1983;35:49-
53.
Dembe K, Karnafel W, Pacuła P. The effect of age on glucose tolerance and B cell secretion.
Pol Arch Med Wewn 1997;97:112-9.
264
Demoule A, Divangahi M, Yahiaoui L, Danialou G, Gvozdic D, Labbe K, Bao W, Petrof BJ.
Endotoxin triggers nuclear factor-kappaB- dependent up-regulation of multiple
proinflammatory genes in the diaphragm. Am J Respir Crit Care Med 2006;174:646-653.
Denu JM, Tanner KG. Specific and reversible inactivation of protein tyrosine phosphatases
by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox
regulation. Biochemistry 1998;37:5633–5642.
Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A,
Verger C, Dahmane D, de Groote D, Jungers P. Balance between IL-1β, TNF-α, and their
specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with
activation markers of T cells, B cells, and monocytes. J Immunol 1995;154:882–892.
Descamps-Latscha B, Jungers P, Witko-Sarsat V. Immune system dysregulation in uremia:
role of oxidative stress. Blood Purif 2002;20:481-484.
Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1
expression and activity in human aortic endothelial cells: implications for the metabolic
syndrome and atherothrombosis. Circulation 2003;107:398–404.
De Vega L, Fernandez RP, Martin Mateo MC, Bustamante JB, Herrero AM, Munguira EB.
Glutathione determination and a study of the activity of glutathioneperoxidase, glutathione-
transferase, and glutathione–reductase in renal transplants. Renal Failure 2002;24:421–432.
Diamond GF. Reactive oxygen species and progressive glomerular disease. J Lab Clin Med
1994;124:468-469.
DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive
IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997;388:548–554.
Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk
between Jak2 and NFkappa B signalling cascades. Nature 2001;412:641–647.
Dokshina GA, Silaeva TY, Yartsev EI. Some insulin-like effects of taurine (in Russian).
Vopr Med Khim 1976; 22: 503–507.
Dounousi E, Papavasiliou E, Makedou A, Ioannou K, Katopodis KP, Tselepis A,
Siamopoulos KC, Tsakiris D. Oxidative stress is progressively enhanced with advancing
stages of CKD. Am J Kidney Dis 2006;48:752-60.
Drueke, TB, Khoa TN, Massy ZA, Witko-Sarsat B, Lacour B, Descaps-Latsch B. Role of
oxidized low density lipoprotein in the atherosclerosis of uremia. Kidney Int Suppl
2001;78:S114-S119.
Drueke TB, Rostand SG. Progresssion of vascular calcification in uraemic patients: can it be
stopped? Nephrol Dial Transplant 2002;17:1365-1368.
265
Dzúric R, Spustová V, Lajdová I. Inhibition of glucose utilization in isolated rat soleus
muscle by pseudouridine: Implications for renal failure. Nephron 1993;65:108-110.
Dzurik R, Valovicova E. Glucose utilization during uremia: In vitro study. Clin Chim Acta
1970;30:137-142.
Dzurik R, Spustova V, Janekova K. The prevalence of insulin resistance in kidney disease
patients before the development of renal failure. Nephron 1995;69:281-285.
Ducluzeau PH. Perretti N, Laville M, Andreelli F, Vega N, Riou JP, Vidal H. Regulation by
insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific
defects in type 2 diabetes. Diabetes 2001;50:1134-1142.
Dunlop ME, Muggli EE. Small heat shock protein alteration provides a mechanism to reduce
mesangial cell contractility in diabetes and oxidative stress. Kidney Int 2000;57,464–475.
E
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28.
Eckl PM, Ortner A, Esterbauer H. Genotoxic properties of 4-hydroxyalkenals and analogous
aldehydes. Mutat Res 1993;290:183–192.
Eidemak I, Feldt-Rasmussen B, Kanstrup IL, Nielsen SL, Schmitz O, Strandgaard S. Insulin
resistance and hyperinsulinemia in mild to moderate progressive chronic renal failure and its
association with aerobic work capacity. Diabetologia 1995;38:565-572.
El-Agouza I, Abu Shola A, Sirdah M. The effect of iron deficiency anaemia on the levels of
haemoglobin subtypes: possible consequences for clinical diagnosis. Clin Lab Haematol
2002;24:285-289.
El-Ghar SM, Qureshi M, Shoker A, Prasad K. Oxidative stress in renal transplant patients
who develop cardiovascular disease. J Cardiovasc Pharmacol Ther 2006;11:203-10.
Elhage R, Clamens S, Besnard S, Mallat Z, Tedgui A, Arnal J, Maret A, Bayard F.
Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak
formation by 17beta-estradiol in apolipoprotein E-deficient mice. Atherosclerosis
2001;156:315–320.
Elizarova EP, Nedosugova LV. First experiments in taurine administration for diabetes
mellitus – the effect on erythrocyte membranes. Adv Exp Med Biol 1996; 403: 583–588.
El-Rashidy FH, Al-Turk WA, Stohs SJ. Glutathione, glutathione reductase and glutathione S-
transferase activities in erythrocytes and lymphocytes in chronic renal disease. Res Commun
Chem Pathol Pharmacol 1984;44:423-430.
266
Eppler B, Dawson Jr. R, Dietary taurine manipulation in aged male Fischer 344 rat tissue:
taurine concentration, taurine biosynthesis, and oxidative markers. Biochem Pharm
2001;62:29-39.
Eric DW, Jongsoon L, Lone H, Minsheng Y, Steven ES. Insulin resistance due to
phosphorylation of insulin receptor substrate-1 at serine 302. J Biol Chem. 2004;279, 35298-
35305.
Escriva F, Agote M, Rubio E, Molero JC, Pascual-Leone AM, Andres A, Satrustegui J,
Carrascosa JM. In vivo insulin-dependent glucose uptake of specific tissues is decreased
during aging of mature Wistar rats. Endocrinology 1997;138:49-54.
Esterbauer H, Wag G, Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bul
1993;49:566–576.
Esterbauer H. Cytotoxicity and genotoxicity of lipid oxidation products. Am J Clin Nutr
1993;57:779S–786S.
Evans JL, Goldfine ID: α-Lipoic acid: a multi-functional antioxidant that improves insulin
sensitivity in patients with type 2 diabetes. Diabetes Technol Ther 2000;2:401–413.
Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated
signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 2002;23:599–622.
Evans JL, Heymann CJ, Goldfine ID, Gavin LA: Pharmacokinetics, tolerability, and
fructosamine-lowering effect of a novel, controlled release formulation of α-lipoic acid.
Endocr Pract 2002;8:29–35.
Evans JL, Goldfine ID,Maddux BA, Grodsky GM. Are oxidative stress activated signaling
pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 2003;52:1–8.
Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin
resistance. Antioxid Redox Signal 2005;7:1040–1052.
F Facchini FS. Effect of phlebotomy on plasma glucose and insulin concentrations. Diabetes
Care 1988;21:2190.
Facchini FS, Humphreys MH, DoNascimento CA, Abbasi F, Reaven GM. Relation between
insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and
tocopherols. Am J Clin Nutr 2000; 72: 776–779.
267
Fantus G, Kadota S, Deragon G, Foster B, Posner BI. Pervanadate (peroxide(s) of vanadate)
mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase.
Biochemistry. 1989;28:8864–8871.
Felber JP, Meyer HU, Curchod B, Iselin HU, Rousselle J, Maeder E, Pahu P, Jequier E.
Glucose storage and oxidation in different degrees of human obesity measured by continuous
indirect calorimetry. Diabetologia 1981;20:3944.
Festa A, D’Agostiono R, Howard G, Mykk nen L, Tracy RP, Haffner SM. Chronic
subclinical inflammation as part of the insulin resistance syndrome; The Insulin Resistance
Atherosclerosis Study (IRAS). Circulation 2000;102:42–47.
Fiorillo C, Oliviero C, Rizzuti G, Nediani C, Pacini A, Nassi P. Oxidative stress and
antioxidant defences in renal patients. Clin Chem Lab Med 1998;36:149-153.
Fichtscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM. Elevated C
reactive protein levels and impaired endothelial vasoreactivity in patients with coronary heart
disease. Circulation 2000;102:1000–1006.
Fisher CJ, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM,
Benjamin E. Treatment of septic shock with the tumour necrosis factor: Fc fusion protein. N
Engl J Med 1996;334:1697–1702.
Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, Ritz E. Insulin
resistance and hyperinsulinemia are already present in patients with incipient renal disease.
Kidney Int 1998;53:1343-1347.
Floccari F, Aloisi C, Crascì E, Sofi T, Campo S, Tripodo D, Criseo M, Frisina N, Buemi M.
Oxidative stress and uremia. Med Res Rev 2005;25:473-86.
Fluckiger R, Harmon W, Meier W, Loo S, Gabbay K. Hemoglobin carbamylation in uremia.
N Engl J Med 1981;304:823-827.
Foley RN, Parfrey PS, Sarnak JM. Cardiovascular disease in chronic renal disease. Clinical
epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S
112-119.
Fong KL, McCay PB, Poyer JL. Evidence for superoxide-dependent reduction of Fe3+ and its
role in enzyme-generated hydroxyl radical formation. Chem Biol Interaction 1976;15:77-89.
Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count:
findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis
2003; 168;351–358.
Ford HC, Chew-Lim W, Crooke MJ. Hemoglobin A1C and serum fructosamine levels in
hyperthyroidism. Clin Chim Acta 1987;166: 317-321.
268
Franconi F, Bennardini F, Mattana A, Miceli M, Ciuti M, Mian M, Gironi A, Anichini R,
Seghieri G. Plasma and platelet taurine are reduced in subjects with insulin-dependent
diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 1995; 61: 1115–1119.
Franconi F, Miceli M, Fazzini A, Seghieri G, Caputo S, DiLeo MA, Lepore D, Ghirlanda G.
Taurine and diabetes – humans and experimental models. Adv Exp Med Biol 1996;403: 579–
582.
Freedman D, Dandona P, Fernando O, Moorhead JF. Glycosylated haemoglobin in chronic
renal failure and after renal transplantation. J Clin Pathol 1982;35:737-739.
Freeman BD. Biological sites and mechanisms of free radical production. In: Free Radicals in
Molecular Biology, Aging, and Disease, edited by Armtrong D, Sohal RS, Cutler RG and
Slater TF. New York: Raven, 1984, p 43-52.
Frei B, Higdon JV. Antioxidant activity of tea polyphenols in vivo: evidence from animal
studies. J Nute 2003;133:6190-6195.
Fridovich I. Superoxide dismutases. Annu Rev Biochem 1975;44:147-159.
Fridovich I. The biology of oxygen radicals. Science 1978;201:875-880.
Friedman JE, Dohm GL, Elton CW, Rovira A, Chen JJ, Leggett-Frazier N, Atkinson SM Jr,
Thomas FT, Long SD, Caro JF. Muscle insulin resistance in uremic humans: glucose
transport, glucose transporters, and insulin receptors. Am J Physiol 1991;261:E87-94.
Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M. Systemic oxidative
stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J
2006;70:1437–1442.
Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M, Onishi Y, Ono H, Abe M,
Shojima N, Fukushima Y, Kikuchi M, Oka Y, Asano T. Three mitogen-activated protein
kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes. Mol
Endocrinol 2003;17:487–497.
Fulop T, Larbi A, Douziech N. Insulin receptor and ageing. Pathol Biol 2003;51:574-80.
Furth AJ. Glycated proteins in diabetes. Br J Biomed Sci 1997;54:192–200.
Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O,
Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact
on metabolic syndrome. J Clin Invest. 2004;114:1752-61.
269
G Galle J, Heinloth A, Schwedler S Wanner C. Effect of HDL and atherogenic Hpoproteins on
formation of O2'- and renin release in juxtaglomerular cells. Kidney Int 1997; 51:253-260.
Galle J, Schneider R, Winner B Lehmann-Bodem C, Schinzel R, Munch G, Conzelmann E,
Wanner. Glyc-oxidized LDL impair endothelial fiinction more potently than oxidized LDL:
Role of enhanced oxidative stress. Atherosclerosis 1998; 138:65-77.
Galle J. Oxidative stress in chronic renal failure. Nephrol Dial Transplant 2001;16:2135-
2137.
Garg AX, Blake PG, Clark WF, Clase CM, Haynes RB, Moist LM. Association between
renal insufficiency and malnutrition in older adults: Results from the NHANES III. Kidney
Int 2001;60:1867–1874.
Gallardo JM, de Carmen Prado-Uribe M, Amato D, Paniagua R. Inflammation and oxidative
stress markers by pentoxifylline treatment in rats with chronic renal failure and high sodium
intake. Arch Med Res 2007;38:34-8.
Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, Ye J. Serine phosphorylation of
insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem
2002;277:48115–48121.
Gao Z, Zhang X, Zuberi A, Hwang D, Quon MJ, Lefevre M, Ye J. Inhibition of insulin
sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1
adipocytes. Mol Endocrinol. 2004;18:2024-34.
Gao Z, Zuberi A, Quon MJ, Dong Z, Ye J. Aspirin inhibits serine phosphorylation of insulin
receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine
kinases. J Biol Chem 2003;278:24944–24950.
Garibotto G, Sofia A, Procopio V, Villaggio B, Tarroni A, Di Martino M, Cappelli V,
Gandolfo MT, Aloisi F, De Cian F, Sala MR, Verzola D. Peripheral tissue release of
interleukin-6 in patients with chronic kidney diseases: effects of end-stage renal disease and
microinflammatory state. Kidney Int 2006;70:384-390.
Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W,
Goldman M, Velu T. Interleukin-10 reduces the release of tumor necrosis factor and prevents
lethality in experimental endotoxemia. J Exp Med 1993;177:547–550.
Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved
mediators of immune responses. Annu Rev Immunol 1998;16:225–260.
270
Granberry MC, Fonseca VA. Insulin resistance syndrome: options for treatment. South Med J
1999;92:2–15.
Granger DN, Rutili G, McCord JM. Superoxide radicals in feline intestinal ischemia.
Gasteroenterology 81; 22-29: 1981.
Goldberg A, Hagberg J, Delmez J, Haynes ME, Harter HR. The metabolic effects of exercise
training in hemodialysis patients. Kidney Int 1989;18:754-761.
Goldstein BJ. Protein-tyrosine phosphatases: emerging targets for therapeutical intervention
in type 2 diabetes and related states of insulin resistance. J Clin Endocrinol Metab
2002;87:2474-2480.
Gomes A, Vedasiromone JR, Das M, Sharma RM, Ganguly DK. Antihyperglycemic effect of
black tea in rat. J Enthanopharmacol 1994;45:223-226.
Goodman HO, Shihabi ZK. Supplemental taurine in diabetic rats: effects on plasma glucose
and triglycerides. Biochem Med Metab Biol 1990; 43: 1–9.
Green TR, Fellman JH, Eicher AL, Pratt KL. Antioxidant role and subcellular location of
hypotaurine and taurine in human neutrophils. Biochim Biophys Acta 1991;1073:91-97.
Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Prager R,
Schnack C, Schernthaner G. Enhanced serum levels of thiobarbituric acid reactive substances
in diabetes mellitus. Am J Med 1995; 98:469–475.
Griselli M, Herbert J, Hutchinson WL, Taylor KM, Sohail M, Krausz T, Pepys MB. C-
reactive protein and complement are important mediators of tissue damage in acute
myocardial infarction. J Exp Med 1999;190:1733–1740.
Guo Q, Zhao B, Li M, Sthen S, Xin W. Studies on protective mechanisms of four
components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochem
Biophys Acta 1996;1304:210-222.
H
Haber CA, Lam TK, Yu Z, Gupta N, Goh T, Bogdanovic E, Giacca A, Fantus IG. N-
acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible
role of oxidative stress. Am J Physiol Endocrinol Metab 2003;285:E744-53.
Haber F, Weiss JJ. The catalytic decomposition of hydrogen peroxide by iron salts. Proc R
Soc London 1934;A147:332–351.
271
Hagar HH, Etter EE, Arafa M. Taurine attenuates hypertension and renal dysfunction induced
by cyclosporine A in rats. Clin Exper Pharm Physiol 2006;33:189-196.
Hainque B. Adipose tissue IL-6 content correlates with resistance to insulin activation of
glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002;87:2084–2089.
Haley RJ, Ward DM. Nonenzymatically glucosylated serum proteins in patients with end-
stage renal failure. Am J Kidney Dis 1986;8: 115-121.
Halliwell B, Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease.
Biochem J 1984;219:1–14.
Halliwell B, Gutteridge JMC. The antioxidants of human extracellular fluids. Arch Biochem
Biophys 1990;289:1-8.
Han JS, Kim YS, Chin HJ, Joen US, Ahn C, Kim S, et al. Temporal changes and reversibility
of carbamylated hemoglobin in uremia. Nephrol Dial Transplant 1989;4:96-100.
Handelman GJ, Walter MF, Adhikarla R, Gross J, Dallal GE, Levin NW, Blumberg JB.
Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int
2001;51:1960–1966.
Hansen LL, Ikeda Y, Olsen GS, Busch AK, Mosthaf L. Insulin signaling is inhibited by
micromolar concentrations of H2O2. Evidence for a role of H2O2 in tumor necrosis factor
alpha-mediated insulin resistance. J Biol Chem 1999;274:25078–25084.
Harber F, Weiss JJ. The catalytic decomposition of hydrogen peroxide by iron salts. Proc R
Soc Lond Ser A 1981;147: 332-351.
Harding JJ. Post-translational modification of lens proteins in cataract. Lens Eye Tox Res
1991;8:245-250.
Haring HU. The insulin receptor: signalling mechanism and contribution to the pathogenesis
of insulin resistance. Diabetologia 1991;34:848-861.
Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol
1956;11:298–300.
Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H,
Cohen HJ, Wallace R. Association of elevated interleukin-6 and C-reactive protein levels
with mortality in the elderly. Am J Med 1999;106:506–512.
Hasselwander O, Young IS: Oxidative stress in chronic renal failure. Free Radic Res
1998;29:1-11.
Haugen E, Nath KA. The involvement of oxidative stress in the progression of renal injury.
Blood Purif 1999;17:58-65.
272
Hayes GR, Lockwood DH. Role of insulin receptor phosphorylation in the insulinomimetic
effects of hydrogen peroxide. Proc Natl Acad Sci U S A. 1987;84:8115–8119.
Heaton A, Taylor R, Johnston DG, Ward MK, Wilkinson R, Alberti KGGM. Hepatic and
peripheral insulin action in chronic renal failure before and during continuous ambulatory
peritoneal dialysis. Clin Sci 1989;77:383-388.
Heffetz D, Bushkin I, Dror R, Zick Y. The insulinomimetic agents H2O2 and vanadate
stimulate protein tyrosine phosphorylation in intact cells. J Biol Chem. 1990;265:2896–2902.
Heliovaara MK, Teppo AM, Karonen SL, Tuominen JA, Ebeling P. Plasma IL-6
concentration is inversely related to insulin sensitivity, and acutephase proteins associate with
glucose and lipid metabolism in healthy subjects. Diabetes Obes Metab 2005;7:729–736.
Hession C, Decker JM, Sherblom AP, Kumar S, Yue CC, Mattaliano RJ, Tizard R,
Kawashima E, Schmeissner U, Heletky S. Uromodulin (Tamm-Horsfall glycoprotein): A
renal ligand for lymphokines. Science 1987;237:1479–1484.
Himmelfarb J, McMonagle E, McMenamin E. Plasma protein thiol oxidation and carbonyl
formation in chronic renal failure. Kidney Int 2000;58:2571– 8.
Himmelfarb J, Stenvinkel P, Ikizler A, Stenvinkel P. The elephant of uremia: oxidative stress
as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002;62:1524-38.
Himmelfarb J, Hakim RM. Oxidative stress in uremia. Curr Opin Nephrol Hypertens
2003;12:593-598.
Hirosumi J, Tuncman G, Chang L, Gorzun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil
GS. A central role of JNK in obesity and insulin resistance. Nature 2002;420:333-336.
Ho FM, Liu SH, Liau CS, Huang PJ, Lin-Shiau SY. High glucose-induced apoptosis in
human endothelial cells is mediated by sequential activations of c- JunNH(2)-terminal kinase
and caspase-3. Circulation 2001;101:2618–2624.
Holtham SB, Schutz F. The effect of cyanate on the stability of proteins. Biochem Biophys
Acta 1949;3:65-81.
Horkko S, Savolainen MJ, Kervinen K, Kesaniemi YA. Carbamylation-induced alterations in
low-density lipoprotein metabolism. Kidney Int 1992;41:1175-1181.
Hostetter TH. Prevention of the development and progression of renal disease J AM Soc
Nephrol 2003;14:S144-S147.
Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha
inhibits signalling from the insulin receptor. Proc Natl Acad Sci USA 1994;91:4854–4858.
273
Hotamisligil GS, Arner P, Caroj F, Atkinson RL, Spiegelman BM. Increased adipose tissue
expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin
Invest 1995;95:2409–2415.
Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple
forms of insulin resistance. Nature 2006;440:944–948.
Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal
endotoxemia. J Exp Med 1993;177:1205–1208.
Hu ML, Louie S, Motchik P, Halliwell B. Antioxidant protection against hypochlorous acid
in human plasma. J Lab Clin Med 1993; 121: 257–262.
Huber SA, Sakkinen P, Conzed D, Hardin N, Tracy R. Interleukin-6 exacerbates early
atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1999;19:2364–2367.
Huang Y, Domann FE. Redox modulation of AP-2 DNA binding activity in vitro. Biochem
Biophys Res Commun 1998;249, 307–312.
Hundal RS, Mayerson AB, Petersen KF, Rife FS, Randhawa PS, Inzucchi SE, Shoelson SE,
Shulman GI. Potential for a novel class of insulin sensitizing agents by inhibition of IKKβ
activity (Abstract). Diabetes 2001;A117.
Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek W, Rogers NL, Teschan
PE. Predictors of the progression of renal disease in the modification of diet in renal disease
study. Kidney Int 1997;51:1908-1919.
I
Iiyama K, Hajra L, Iiyama M, Li H, DiChiara M, Medoff BD, Cybulsky MI. Patterns of
vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit
and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res
1999;85:199–207.
Ikizler TA, Morrow JD, Roberts LJ, Evanson JA, Becker B, Hakim RM, Shyr Y, Himmelfarb
J. Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol
2002;58:190–197.
Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, Farahifar
D, Rossi B, Auberger P, Baeuerle PA, Peyron JF. Tyrosine phosphorylation of I kappa B-
alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell
1999;86:787–798.
274
Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, Okamura M, Okada S,
Yamakawa T, Ishimura E, Nishizawa Y; Osaka CKD Expert Research Group. Glycated
albumin is a better indicator than glycated hemoglobin values in hemodialysis patients with
diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 2007;18:896-903.
Inal M, Kanbak G, Sen S, Akyuz F, Sunal E. Antioxidant status and lipid peroxidation in
hemodialysis patients undergoing erythropoietin and erythropoietin-vitamin E combined
therapy. Free Radic Res 1999;31:211– 216.
Inouye M, Hashimoto H, Mio T, Sumino K. Levels of lipid peroxidation product and
glycated hemoglobin A1C in the erythrocytes of diabetic patients. Clin Chim Acta
1998;276:163-172.
Inouya M, Mio T, Sumino K. Glycated hemoglobin and lipid peroxidation in erythrocytes of
diabetic patients. Metabolism 1999;48:205-209.
Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI. Efficacy
and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J
Med 1998;338:867–872.
J Jacob S, Lehmann R, Rett K, Haring H-U: Oxidative stress and insulin action: a role for
antioxidants. In Antioxidants in Diabetes Management. Packer L, Ro¨ sen P, Tritschler HJ,
King GL, Eds. New York, Marcel Dekker, 2000, p. 319–338 .
Jacobson HR. Chronic renal failure; pathophysiology. Lancet 1991;338:419-423.
Jager J, Gremeaux T, Cormont M, et al. Interleukin-1beta induced insulin resistance in
adipocytes through down-regulation of insulin receptor substrate-1 expression.
Endocrinology 2007;148:241-251.
Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in
human red blood cells. J Biol Chem 1989;264:21340– 5.
Jain SK. The effect of oxygen radicals, metabolites and vitamin E on glycation of proteins in
red blood cells. Diabetes 1993;42:105A.
Jain SK, McVie R. Effect of glycemic control, race (white vs. black), and duration of diabetes
on reduced glutathione content in erythrocytes of diabetic patients. Metabolism 1994;43:306-
309.
Jain SK. Glutathione and glucose-6-phosphate dehydrogenase deficiency can increase protein
glycosylation. Free Radic Biol Med 1998;24:197–201.
275
Jain SK, Lim G. Lipoic acid decreases lipid peroxidation and protein glycosylation and
incareses (Na++ K+) and Ca++-ATPase activities in high glucose-treated human erythrocytes.
Free Radic Biol Med 2000;29:1122-1128.
Jain SK, Rains J, Jones K. Effect of Curcumin on protein glycosylation, lipid peroxidation,
and oxygen radical generation in human red blood cells exposed to high glucose levels. Free
Radic Biol Med 2006;41:92-96.
Jakus V, Hrnciarova M, Carsky J, Krahulec B, Rietbrock N. Inhibition of nonenzymatic
protein glycation and lipid peroxidation by drugs with antioxidant activity. Life Sci
1999;65:1991-1993.
Jensen M, Nathan DG, Bunn HF. The reaction of cyanate with the a and b subunits in
hemoglobin. J Biol Chem 1973;248:8057-8063.
Jocelyn PC. Spectrophotometric assay of thiols. Methods in Ezymol 1987; 143: 44-67.
Johansson M, M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Lambert G, Friberg P.
Increased sympathetic nerve activity in renovascular hypertension. Circulation 1999;99:2537-
2542.
Jones SA, Horiuchi S, Topley N, Le Marchand-Brustel Y, Tanti JF. The soluble interleukin 6
receptor: Mechanisms of production and implications in disease. FASEB J 2001;15:43–58.
John WG. Glycated haemoglobin analysis. Ann Clin Biochem 1997;34:17– 31.
Johnstoone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired
endothelium -dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Circulation 1993;88:2510-2516.
Joy MS, Cefalu WT, Hogan SL, Nachman PH. Long-term glycemic control measurements in
diabetic patients receiving hemodialysis. Am J Kidney Dis 2002;39:297-307.
K
Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA
2005;294:2751-2757.
Kadota S, Fantus IG, Deragon G, Guyda HJ, Posner BI. Stimulation of insulin-like growth
factor II receptor binding and insulin receptor kinase activity in rat adipocytes. J Biol Chem.
1987;262:8252–8256.
Kahn CR. Insulin action, diabetogenes, and the cause of type 2 diabetes. Diabetes
1994;43:1066–1084.
276
Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000;106:473-481.
Kalantarinia K, Awad AS, Siragy HM. Urinary and renal interstitial concentrations of TNF-
alpha increase prior to the rise in albuminuria in diabetic rats. Kidney Int 2003;64:1208–
1213.
Kalantar-Zadeh K, Balakrishnan VS. The kidney disease wasting: inflammation, oxidative
stress, and diet-gene interaction. Hemodial Int 2006;10:315-325.
Kallner AB, Hartmann D, Hornig DH. On the requirements of ascorbic acid in man: steady-
state turnover and body pool in smokers. Am J of Clin Nutr 1981; 34: 1347-1355.
Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka TA, Matsuhisa M, Yamasaki
Y. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in
pancreatic beta-cell dysfunction and insulin resistance. Int J Biochem Cell Biol 2006;38:782-
793.
Karin M. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J Biol
Chem 1999;274:27339–27342.
Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of
proinflammatory signaling. Semin Immunol 2000;12:85–98.
Karin M, Takahashi T, Kapahi P, Delhase M, Chen Y, Makris C, Rothwarf D, Baud V, Natoli
G, Guido F, Li N. Oxidative stress and gene expression: the AP-1 and NFkappa B
connections. Biofactors 2001;15:87–89.
Karin M, Ben-Neriah Y. Regulatory functions of ubiquitination in the immune system. Nat
Immunol 2002;3:20–26
Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002;3:221–
227.
Karkar AM, Koshino Y, Cashman SJ, et al. Passive immunization against tumour necrosis
factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in
nephrotoxic nephritis in rats. Clin Exp Immunol 1992;90:312–318.
Karkar AM, Smith J, Pusey CD. Prevention and treatment of experimental crescentic
glomerulonephritis by blocking tumour necrosis factor-alpha. Nephrol Dial Transplant
2001;16:518–524.
Kasai T, Inada K, Takakuwa T, Yamada Y, Inoue Y, Shimamura T, Taniguchi S, Sato S,
Wakabayashi G, Endo S. Anti-inflammatory cytokine levels in patients with septic shock.
Res Commun Mol Pathol Pharmacol 1997;98:34–42.
Kato Jr T, Delhase M, Hoffmann A, Karin M. CK2 Is a C-Terminal IkappaB Kinase
Responsible for NF-kappaB Activation during the UV Response. Mol Cell 2003;12:829–839.
277
Kato A, Takita T, Maruyamay, Hishida A. Chlamydial infection and progression of carotid
atherosclerosis in patients on regular haemodialysis. Nephrol Dial Transplant 2004;19:2539–
2546.
Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative
insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in
humans. J Clin Endocrinol Metab 2000;85:2402–10.
Kawabata T, Packer L. Alpha-lipoate can protect against glycation of serum albumin, but not
low density lipoprotein. Biochem Biophys Res Commun 1994;203:99-104.
Keane WF. Proteinuria: its clinical importance and role in progressive renal disease. Am J
Kidney Dis 2000; 35: S97-S105.
Keren P, Rina H, Derek L. Molecular basis of insulin resistance: Elevated Serine/Threonine
phosphorylation of IRS-1 and IRS-2 inhibits their binding to the jextamembrane region of the
insulin receptor and impairs their ability to undergo insulin induced tyrosine phosphoryla-
tion. J Biol Chem 1997;272, 29911-29918.
Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis
factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol
2001;280:E745–E751.
Khan SG, Kattiyar SK, Agarwal R, Mukhtar H. Enhancement of antioxidant and phase II
enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice
possible role in cancer chemoprvention. Cancer Res 1992;52:4050-4052.
Kher V. End-stage renal disease in developing countries. Kidney Int 2002; 62: 350–62.
Kietzmann T, Fandrey J, Acker H. Oxygen radicals as messengers in oxygen-dependent gene
expression. News Physiol Sci. 2000;15:202–208.
Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P,
Shoelson SE, Shulman GI. Prevention of fat-induced insulin resistance by salicylate. J Clin
Invest 2001;108:437-446.
Kim HJ, Higashimori T, Park SY, Choi H, Dong J, Kim YJ, Noh HL, Cho YR, Cline G, Kim
YB, Kim JK. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin
action in vivo. Diabetes 2004;53:1060–1067.
Kim HJ, Hawke N, Baldwin AS. NF-kappa B and IKK as therapeutic targets in cancer. Cell
Death Differ 2006;13:738-747.
Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, Cruz I, Yanovski
JA, Veis JH. Immunologic function and survival in hemodialysis patients. Kidney Int
1998;54:236–244.
278
Kislinger T, Tanji N, Wendt T, Qu W, Lu Y, Ferran LJ Jr, Taguchi A, Olson K, Bucciarelli
L, Goova M, Hofmann MA, Cataldegirmen G, D'Agati V, Pischetsrieder M, Stern DM,
Schmidt AM.Receptor for advanced glycation end products mediates inflammation and
enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.
Arteriosclerosis Thromb Vasc Biol 2001;21:905-910.
Kitiyakara C, Gonin J, Massy Z, Wilcox CS. Non-traditional cardiovascular disease risk
factors in end-stage renal disease: oxidative stress and hyperhomocysteinemia. Curr oin
Nephrol Hypertens 2000;9:477-487.
Klover PJ, Zimmers TA, Koniaris LG, Mooney RA. Chronic exposure to interleukin-6
causes hepatic insulin resistance in mice. Diabetes 2003;52:2784–2789.
Klemm A, Voigt C, Friedrich M, Fünfstück R, Sperschneider H, Jäger EG, Stein G.
Determination of erythrocyte antioxidant capacity in haemodialysis patients using electron
paramagnetic resonance. Nephrol Dial Transplant 2001;16:2166-71.
Knight JA. Biochmeistry of aging. Adv Clin Chem 2000;35:1-62.
Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T. Insulin resistance in patients with
chronic kidney disease. Am J Kidney Dis 2005;45:275-280.
Kolterman OG, Insel J, Saekow M, Olefsky JM. Mechanisms of insulin resistance in human
obesity: evidence for receptor and post-receptor defects. J Clin Invest 1980;65:1272-1284.
Koner BC, Banerjee BD, Ray A. Effects of in vitro generation of oxygen free radicals on
immune responsiveness in rabbits. Immunol Lett 1997;59:127-31.
Korish AA, Arafah MM. Catechin combined with vitamins C and E ameliorates insulin
resistance (IR) and atherosclerotic changes in aged rats with chronic renal failure (CRF).
Arch Gerontol Geriatr. 2008;46:25-39.
Koshio O, Akanuma Y, Kasuga M. Hydrogen peroxide stimulates tyrosine phosphorylation
of the insulin receptor and its tyrosine kinase activity in intact cells. Biochem J. 1988;250:95–
101.
Kosmidou I, Vassilakopoulos T, Xagorari A, Zakynthinos S, Papapetropoulos A, Roussos C.
Production of interleukin-6 by skeletal myotubes: Role of reactive oxygen species. Am J
Respir Cell Mol Biol 2002;26:587–593.
Kovarik J, Stummvoll HK, Graf H, Muller MM. Glucose intolerance and hemoglobin A1 in
chronic renal insufficiency. Nephron 1981;28:209-212.
Krieger-Brauer HI, Kather H. Human fat cells possess a plasma membrane-bound H2O2
generating system that is activated by insulin via a mechanism bypassing the receptor kinase.
J Clin Invest 1992;89:1006–1013.
279
Kulakowski EC, Maturo J. Hypoglycemic properties of taurine: not mediated by enhanced
insulin release. Biochem Pharmacol 1984; 33: 2835–2838.
Kumar A, Lnu S, Malya R, Barron D, Moore J, Corry DB, Boriek AM. Mechanical stretch
activates nuclear factor-kappaB, activator protein-1, and mitogen-activated protein kinases in
lung parenchyma: implications in asthma. FASEB J 2003;17:1800–1811.
Kumar A, Takada Y, Boriek AM, Aggarwal BB. Nuclear factor-kB: its role in health and
disease. J Mol Med 2004; 82:434–448.
Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the
vasculature. Circ Res 1999;85:753–66.
L
Lagrand WK, Visser CA, Hermens WT , Niessen HW, Verheugt FW, Wolbink GJ, Hack CE.
C-reactive-protein as a cardiovascular risk: more than an epiphenomenon? Circulation
1999;100:96–102.
Lahera V, Goicoechea M, De Vinuesa SG, Oubi a P, Cachofeiro V, Gomez-Campdera F,
Amann R, Luno J. Oxidative stress in uremia: The role of anemia correction. J Am Soc
Nephrol 2006;17:S174-S177.
Lamb RE, Goldstein BJ. Modulating an oxidative-inflammatory cascade: potential new
treatment strategy for improving glucose metabolism, insulin resistance, and vascular
function. Int J Clin Pract 2008;62:1087–1095.
Lampson WG, Kramer JH, Schaffer SW. Potentiation of the actions of insulin by taurine. Can
J Physiol Pharmacol 1983; 61: 457–463.
Landray MJ, Wheeler DC, Lip GY, Newman DJ, Blann AD, McGlynn FJ, Ball S, Townend
JN, Baigent C. Inflammation, endothelial dysfunction, and platelet activation in patients with
chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J
Kidney Dis 2004;43:244–253.
Lapolla A, Fedele D, Plebani M, Aronica R, Garbeglio M, Seraglia R, D'Alpaos M, Traldi P.
Evaluation of glycated globins by matrix-assisted laser desorption/ionization mass
spectrometry. Clin Chem 1999;4:288– 90.
Lapolla A, Traldi P, Fedele D. Importance of measuring products of non-enzymatic glycation
of proteins. Clin Biochem 2005;38:103-115.
280
Larriviere F, Chiasson JL, Schiffrin A, Taveroff A, Hoffer LJ. Effects of dietary protein
restriction on glucose and insulin metabolism in normal and diabetic humans. Metabolism
1994;43:462-467.
Larsen ML. The clinical usefulness of glycated haemoglobin in diabetes care evaluated by
use of a medical technology assessment strategy. Dan Med Bull 1997;303– 15.
Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA. Possible new role for NF-
kappaB in the resolution of inflammation. Nat Med 2001;7:1291–1297.
Lawrence JC Jr, Roach PJ. New insights into the role and mechanism of glycogen synthase
activation by insulin. Diabetes 1997;46:541-547.
Le Hir M, Haas C, Marino M, Ryffel B. Prevention of crescentic glomerulonephritis induced
by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice. Lab Invest
1998;78:1625–1631.
Lee JA, Lee HR, Sadler PJ. Uraemia: is urea more important than we think? Lancet
1991;38:1438-1440.
Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, Adams JL. Inhibition of p38
MAP kinase as a therapeutic strategy. Immunopharmacology 2000; 47: 185–201.
Lee FS, Peters RT, Dang LC, Maniatis T. MEKK1 activates both IkappaB kinase alpha and
IkappaB kinase beta. Proc Natl Acad Sci USA 1998;95:9319–9324.
Lee HS, Song CY.Oxidized Low-Density Lipoprotein and Oxidative Stress in the
Development of Glomerulosclerosis. Am J Nephrol. 2008;29:62-70.
Lee SR, Yang KS, Kwon J, Lee C, Jeong W, Rhee SG. Reversible inactivation of the tumor
suppressor PTEN by H2O2. J Biol Chem 2002;277:20336–20342.
LeRoith D, Zick Y. Recent advances in our understanding of insulin action and insulin
resistance. Diabetes Care 2001;24:588-597.
Leung HW, Vang MJ, Mavis RD. The cooperative interaction between vitamin E and vitamin
C in suppression of peroxidation of membrane phospholipids. Biochim Biophys Acta 1973;
664: 266-272.
Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor
necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236–241.
Lewis TS, Shapiro PS, Ahn NG, 1998. Signal transduction through MAP kinase cascades. In:
Woude GFV, Klein G, eds. Advances in cancer research. San Diego: Academic Press Inc.;
vol 74, 49–139.
281
Li X, Chen H, Epstein PN. Metallothionein and catalase sensitize to diabetes in nonobese
diabetic mice. Reactive oxygen species may have a protective role in pancreatic β-cells.
Diabetes 2006;55:1592-604.
Li W, Hawkins M, Barzilai N, Rhodes CJ, Fantus IG, Brownlee M, Scherer PE. The
hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen
species. J Biol Chem 2005;280:4617–4626.
Li N, Karin M. Is NF-kappaB the sensor of oxidative stress? FASEB J 1999;13:1137-1143.
Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol
2002;2:725-734.
Ligier S, Fortin PR, Newkirk MM.A new antibody in rheumatoid arthritis targeting glycated
IgG: IgM anti-IgG-AGE. Br J Rheumatol. 1998;37:1307-14.
Lin Y, Berg AH, Iyengar P, Lam TK, Giacca A, Combs TP, Rajala MW, Du X, Rollman B,
Lindsay RM, Smith W, Lee WK, Dominiczak MH, Baird JD. The effect of δ-gluconolactone,
an oxidized analogue of glucose, on the nonenzymatic glycation of human and rat
hemoglobin. Clin Chim Acta 1997;263:239–47.
Ling L, Cao Z, Goeddel DV. NF-kappaB-inducing kinase activates IKK-alpha by
phosphorylation of Ser-176. Proc Natl Acad Sci USA 1998;95:3792–3797.
Locatelli F, Amico MD, Cernevskis H, Dainys B, Miglinas M, Luman M, Ots M, Ritz E. The
epidemiology of end-stage renal disease in the Baltic countries: an evolving picture. Nephrol
Dial Transplant 2001;16: 1338-42.
Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in
end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant
2003;18:1272-1280.
London GM, Parfrey PS. Cardiac disease in chronic uremia: pathogenesis. Adv Ren Replace
Ther 1997;4:194-211.
Lu D, Maulik N, Moraru II, Kreutzer DL, Das DK. Molecular adaptation of vascular
endothelial cells to oxidative stress. Am J Physiol 1993;264:C715–C722.
Lundgren M, Svensson M, Lindmark S, Renstrom F, Ruge T, Eriksson JW. Fat cell
enlargement is an independent marker of insulin resistance and ‘hyperleptinaemia’.
Diabetologia 2007;50:625–633.
Lyons TJ. Glycation, oxidation and glycoxidation reactions in the development of diabetic
complications. Contrib Nephrol 1995;112:1– 10.
282
M
Macallum AB, Sivertz C. The potentiation of insulin by sulfones. Can Chem Process Ind
1942; 26: 569.
MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. Nitration and
inactivation of manganese superoxide dismutase in chronic rejection of human renal
allografts. Proc Natl Acad Sci USA 1996;93:11853–11858.
Maddux BA, See W, Lawrence JC Jr, Goldfine AL, Goldfine ID, Evans JL: Protection
against oxidative stress-induced insulin resistance in rat L6 muscle cells by micromolar
concentrations of α-lipoic acid. Diabetes 2001;50:404–410.
Madrid LV, Mayo MW, Reuther JY, Baldwin AS Jr. Akt stimulates the transactivation
potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase
and activation of the mitogen-activated protein kinase p38. J Biol Chem 2001;276:18934-40.
Majer M, Popov KM, Harris RA, Bogardus C, Prochazka M. Insulin down regulates pyruvate
dehydrogenase kinase (PDK) mRNA: potential mechanism contributing to increased lipid
oxidation in insulin-resistant subjects. Mol Genet Metab 1998;65:181-186.
Mak RHK, Turner C, Thompson T, Haycock GB, Chantler C. The effects of low protein diet
with amino acid/keto acid supplements on glucose metabolism in children with uremia. J Clin
Endocrinol Metab 1986;63:985.
Mak RHK. Carbohydrate metabolism in uremia. Pediatr Nephrol 1989;3:201-208.
Mak RHK. Effect of recombinant human erythropoietin on insulin, amino acid, and lipid
metabolism in uremia. J Pediatr 1996;129:97-104.
Marchant A, Deviere J, Byl B, De Groote D, Vincent JL, Goldman M. Interleukin-10
production during septicaemia. Lancet 1994;343:707–708.
Maritim AC, Sanders RA, Watkins JB 3rd. Effects of alpha-lipoic acid on biomarkers of
oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem 2003;14:288-294.
Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon JM. Circulating interleukin-8
concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care
Med 1994;22:673–679.
Mates JM, Perez-Gomez C, Nunez de Castro I. Antioxidant enzymes and human diseases.
Clin Biochem 1999;32:595– 603.
283
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis
model assessment: insulin resistance and beta-cell function from fasting plasma glucose and
insulin concentrations in man. Diabetologia 1985;28:412–9.
Mayer TK, Freedman ZR. Protein glycosylation in diabetes mellitus: a review of laboratory
measurements and of their clinical utility. Clin Chim Acta 1983;127:147–84.
Mayerson AB, Hundal RS, Dufour S, Lebon V, Befroy D, Cline GW, Enocksson S, Inzucchi
SE, Shulman GI, Petersen KF: The effects of rosiglitazone on insulin sensitivity, lipolysis,
and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. Diabetes
2002;51:797–802.
McCarty MF. Exploiting complementary therapeutic strategies for the treatment of type II
diabetes and prevention of its complications. Med Hypotheses 1997; 49: 143–152.
McCarthy ET, Sharma R, Sharma M, Li JZ, Ge XL, Dileepan KN, Savin VJ. TNF-alpha
increases albumin permeability of isolated rat glomeruli through the generation of
superoxide. J Am Soc Nephrol 1998;9:433–438.
McClung JP, Roneker CA, Mu W, Lisk DJ, Langlais P, Liu F, Lei XG.et al: Development of
insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc
Natl Acad Sci USA 2004;101:8852-8857.
McCord JM, Fridovich I. the utility of superoxide dismutase in studing free radicals. II. The
mechanism of the mediation of cytochrome c reduction by a variety of electron carriers. J.
Biol.Chem 262; 1374-1377: 1970.
McIntyre EA,WalkerM. Genetics of type 2 diabetes and insulin resistance: knowledge from
human studies. Clin Endocrinol (Oxf) 2002;57:303–11.
Mckay DL, Blumberg JB. The role of tea in human health: An update. Journal of the
American College of Nutrition 2002;21:1-13.
Mackenzie HS, Brenner BM. Current strategies for retarding progression of renal disease.
Am J Kidney Dis 1998;31:161-170.
Maritim AA, Sanders RA, Watkins JB III. Diabetes, oxidative stress, and antioxidants: a
review. J Biochem Mol Toxicol 2003;17:24–38.
Mee-Kyuing C, Il-Han K. Glutathione-linked thiol peroxidase activity in human serum
albumin: a possible antioxidant role of serum albumin in blood plasma. Biochem Biophys
Res Commun 1996; 222: 619-625.
Michiels C, Remacle J. Cytotoxicity of linoleic acid peroxides, malondialdehyde and 4-
hydroxynonenal towards human fibroblast. Toxicology 1991;66:225–34.
284
Michieles C, Toussaint O, Remacle J. Comparative study of oxygen toxicity on human
fibroblasts and endothelial cells. J Cell Physiol 1990;144:295–302.
Mimic-Oka J, Simic T, Djukanovic L, Reljic Z, Davicevic Z. Alteration in plasma antioxidant
capacity in various degrees of chronic renal failure. Clin Nephrol 1999;51(4):233– 41.
Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in nonenzymatic
biochemistry in uremia: origin and significance of ‘‘carbonyl stress’’ in long-term uremic
complications. Kidney Int 1999;55:389– 99.
Mizuno T, Matsui H, Imamura A, Numaguchi Y, Sakai K, Murohara T, Okumura K. Insulin
resistance increases circulating malondialdehyde-modified LDL and impairs endothelial
function in healthy young men. Int J Cardiol 2004;97:455–461.
Moeller S, Gioberge S, Brown G. ESRD patients in 2001: global overview of patients,
treatment modalities and development trends. Nephrol Dial Transplant 2002;17: 2071-6.
Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack
SW. Subcutaneous adipose tissue releases interleukin-6, but not tumour necrosis factor-a, in
vivo. J Clin Endocrin Metab 1997;82:4196–4200.
Mohan Kumar KM, Bobby Z, Selvaraj N, Kumar Das A, Chandra Koner B, Sen SK, Ramesh
R, Ranganathan P. Possible link between glycated hemoglobin and lipid peroxidation in
hyperthyroidism. Clin Chim Acta 2004;342:187-192.
Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge
stimulates reactive oxygen species generation by leucocytes. J Clin Endocrinol Metab 2000;
85: 2970–2973.
Moon H-S, Lee H-G, Choi Y-J, Kim T-G, Cho C-S. Proposed mechanisms of (-)-
epugallocatechin-3-gallate for anti-obesity. Chemico-Biological Interactions 2007;167:85-98.
Morehouse LA, Thomas CE, Aust SD. Superoxide-generation by NADPH-cytochrome P-450
reductase: the effect of iron chelators and the role of superoxide in microsomal lipid
peroxidation. Arch Biochem Biophys 232; 366-377: 1984.
Mothe I, Van Obberghen E. Phosphorylation of insulin receptor substrate- 1 on multiple
serine residues, 612, 632, 662, and 731, modulates insulin action. J Biol Chem 1996;271,
11222–11227.
McAuley KA,Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, Duncan
AW. Diagnosing insulin resistance in the general population. Diabetes Care 2001;24:460–4.
Mukhopadhyay A, Manna SK, Aggarwal BB. Pervanadate-induced nuclear factor-kappaB
activation requires tyrosine phosphorylation and degradation of IkappaB alpha. Comparison
with tumor necrosis factor-alpha. J Biol Chem 2000; 275:8549–8555.
285
N
Nadhini ATA, Anuradha CV. Inhibition of lipid peroxidation, protein glycation and elevation
of membrane ion pump activity by taurine in RBC exposed to high glucose. Clin Chim Acta
2003;336:129-135.
Nandhini AT, Thirunavukkarsu V, Anuradha CV. Taurine modifies insulin signaling
enzymes in the fructose-fed insulin resistant rats. Diabetes Metab 2005;31:337-344.
Nakagawa T, Yokozawa T, Terasawa K, Shu S, Juneja LR. Protective activity of green tea
against free radical- and glucose-mediated protein damage. J Agric Food Chem
2002;50:2418-22.
Nakamura T, Ushiyama C, Suzuki S. Effects of taurine and vitamin E on microalbuminuria,
plasma metalloproteinase-9, and serum type IV collagen concentrations in patients with
diabetic nephropathy. Nephron 1999; 83: 361–362.
Nakanishi I, Moutabarrik A, Okada N, Takahara S, Kokado Y, Ishibashi M, Sonoda T.
Interleukin-8 in chronic renal failure and dialysis patients. Nephrol Dial Transplant
1994;9:1435–1442.
Nakao T, Matsumoto H, Okada T, Han M, Hidaka H, Yoshino M. Influence of erythropoietin
treatment on hemoglobin A1C levels in patients with chronic renal failure on hemodialysis.
Intern Med 1998;37:826-830.
Nakatani Y, Kaneto H, Kawamori D, Hatazaki M, Miyatsuka T, Matsuoka TA, Kajimoto Y,
Matsuhisa M, Yamasaki Y, Hori M. Modulation of the JNK pathway in liver affects insulin
resistance status. J Biol Chem. 2004;279:45803-9.
Nakaya Y, Minami A, Harada N, Sakamoto S, Niwa Y, Ohnaka M. Taurine improves insulin
sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2
diabetes. Am J Clin Nutr 2000;71:54-58.
Nara Y, Yamori Y, Lovenberg W. Effect of dietary taurine on blood pressure in
spontaneously hypertensive rats. Biochem Pharmacol 1978;27:2689-92.
Nath KA, Salahudeen AK. Induction of renal groth and injury in the intact rat kidney by
dietary deficiency and antioxidants. J Clin Invest 1990; 86: 1179-1192.
286
Navarro JF, Mora C, Rivero A, Gallego E, Chahin J, Macía M, Méndez ML, García J.
Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced
renal failure: Effects of pentoxifylline administration. Am J Kidney Dis 1999;33:458–463.
Navarro JF, Mora C, Maca M, Garca J. Inflammatory parameters are independently
associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis 2003;42:53–61.
Nguyen-Khoa T, Massy ZA, De Bandt JP, Kebede M, Salama L, Lambrey G, Witko-Sarsat
V, Drueke TB, Lacour B, Thevenin M. Oxidative stress and haemodialysis: role of
inflammation and duration of dialysis treatment. Nephrol Dial Transplant 2001;16:335–340.
Nguyen MTA, Satoh H, Favelyukis S, Babendure JL, Imamura T, Sbodio JI, Zalevsky J,
Dahiyat B, Chi N-W, Olefsky JM. JNK and tumor necrosis factor-α mediate free fatty acid-
induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem 2005;280:35361-35371.
Niskanen LK, Salonen JT, Nyyssonen K, Uusitupa MI. Plasma lipid peroxidation and
hyperglycemia: a connection through hyperinsulinaemia? Diabet Med 1995; 12: 802–808.
Nawawi H, Osman NS, Annuar R, Khalid BA, Yusoff K. Soluble intercellular adhesion
molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary
hypercholesterolaemia treated with atorvastatin. Atherosclerosis 2003;169:283–291.
O Obata T, Brown GE, Yaffe MB. MAP kinase pathways activated by stress: the p38 MAPK
pathway. Crit Care Med 2000;28, N67–N77.
Oberley LW. Free radicals and diabetes. Free Radic Biol Med 1998;5:113–124.
Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J.
Increased prevalence of oxidant stress and inflammation in patients with moderate to severe
chronic kidney disease. Kidney Int 2004; 65:1009-1016.
Odetti P, Garibaldi S, Noberasco G, Aragro I, Valentini S, Traverso N, et al., Levels of
carbonyl groups in plasma proteins of type 2 diabetes mellitus. Acta Diabetologia
1999;36:179–183.
Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide
anion production. J Clin Invest 1993; 91:2546-2551.
Oimoni M, Kubota S, Takagi K, Kawasaki T, Tanke G, Yoshimura Y. Glycosylated
hemoglobin in renal failure. Nephron 1981;28:306.
287
Oimomi M, Matsumoto S, Hatanaka H, Ishikawa K, Kubota S, Yoshimura Y. Determination
of carbamylated plasma protein and its clinical application to renal failure. Nephron
1985;40:405-406.
Okada T, Nakao T, Matsumoto H, Shino T, Nagaoka Y, Tomaru R, Wata T. Association
between markers of glycemic control, cardiovascular complications and survival in type 2
diabetic patients and endstage renal disease. Intern Med 2007;46:807-814.
Okar DA, Lange AJ. Fructose-2,6-bisphosphate and control of carbohydrate metabolism in
eukaryotes. Biofactors 1999;10:1-14.
O'Rahilly S. Insights into obesity and insulin resistance from the study of extreme human
phenotypes. Eur J Endocrinol 2002;147:435–41.
Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M,
Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T,
Matsuzawa Y. Adiponectin, an adipocytes-derived plasma protein, inhibits endothelial NF-
kB signalling through a cAMP-dependent pathway. Circulation 2000;102:1296-1301.
P
Packer L, Rosen P, Tritschler H, King GL, Azzi A (Eds): Antioxidants and Diabetes
Management. New York, Marcel Dekker, 2000.
Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene
1999;18:6853–6866.
Paisey R, Banks R, Holton R, Young K, Hopton M, White D, Hortog M. Glycosylated
hemoglobin in uremia. Diabetic Med 1986;3:445-448.
Pamplona R, Prat J, Cadenas S, Rojas C, Perez-Campo R, Lopez Torres M, Barja G. Low
fatty acid unsaturation protects against lipid peroxidation in liver mitochondria from long-
lived species: the pigeon and human case. Mech Ageing Dev1996; 86:53–66.
Pan X, Niu G, Liu H. Microwave-assisted extraction of tea polyphenols and tea caffeine from
green tea leaves. Chemical Engineering and processing 2003;42:129-133.
Panichi V, Migliori M, De Pietro S, Taccola D, Andreini B, Metelli MR, Giovannini L, Palla
R. The link of biocompatibility to cytokine production. Kidney Int 2000;58:96-103.
Paolisso G, D’Amore A, DiMaro G, Galzerano D, Tesauro P, Varricchio M. Evidence for a
relationship between free radicals and insulin action in elderly. Metabolism 1993; 42: 659–
663.
288
Paolisso G, Giugliano D. Oxidative stress and insulin action. Is there a relationship?
Diabetologia 1996;39:357–363.
Parija M, Bobby Z, Kumar VS, Saradha B. Oxidative stress and protein glycation in patients
with chronic obstructive pulmonary disease. Indian J Physiol Pharmacol 2005;49:95-98.
Park DS, Stefanis L, Yan CYI, Farinelli SE, Greene LA. Ordering the cell death pathway.
Differential effects of BCL2, an interleukin-1-converting enzyme family protease inhibitor,
and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12
cells. J Biol Chem 2001; 271, 21898–21905.
Pecoits-Filho R, Barany B, Lindholm B, Heimbürger O, Stenvinkel P. Interleukin-6 and its
receptor is an independent predictor of mortality in patients starting dialysis treatment.
Nephrol Dial Transplant 2002;17:1684–1688.
Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and
atherosclerosis (MIA) syndrome: the heart of the matter. Nephrol Dial Transplant
2002;17:28-31.
Pecoits-Filho R, Heimbürger O, Bárány P, Suliman M, Fehrman-Ekholm I, Lindholm B,
Stenvinkel P. Associations between circulating inflammatory markers and residual renal
function in CRF patients. Am J Kidney Dis 2003;41:1212–1218.
Peraldi P, Xu M, Spiegelman BM. Thiazolidinediones block tumor necrosis factor-alpha-
induced inhibition of insulin signaling. J Clin Invest 1997;100:1863-1869.
Pessin JE, Saltiel AR. Signalling pathways in insulin action: molecular targets of insulin
resistance. J Clin Invest 2000;106:165-169.
Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE. Her-2/neu
overexpression induces NFkappaB via a PI3-kinase/Akt pathway involving calpain-mediated
degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene
2001; 20:1287–1299.
Pickavance, L.C., Wilding, J.P., 2001. Effects of S 15511, a therapeutic metabolite of
insulin sensitizing agent S15261, in Zucker Diabetic Fatty rat. Diabetes Obes Metab 2001;9:
114-120.
Pieri C, Testa R, Marra M, Bonfigli AR, Manfrini S, Testa I. Age dependent changes of
serum oxygen radical scavenger capacity and haemoglobin glycosylation in non-insulin-
dependent diabetic patients. Gerontology 2001;47:88-92.
Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in
human septic shock: Clin J Am Soc Nephrol 2006;1:979–986.
289
Pirola L, Johnston AM, Van Obberghen E. Modulation of insulin action. Diabetologia
2004;47:170–84.
Pjodkowaki RA, Grotz VL, Mudalar S, Henry RR. The effects of alpha lipoic acid on glucose
homeostasis in type 2 diabetes. J Invest Med 2002;50:71A.
Poole S, Bird TA, Selkirk S, Gaines-Das RE, Choudry Y, Stephenson SL, Kenny AJ,
Saklatvaa J. Fate of injected interleukin 1 in rats: Sequestration and degradation in the
kidney. Cytokine1990; 2:416–422.
Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6,
and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327–334.
Purcell NH, Yu C, He D, Xiang J, Paran N, DiDonato JA, Yamaoka S, Shaul Y, Lin A.
Activation of NF-kappaB by hepatitis B virus X protein through an IkappaB kinase
independent mechanism. Am J Physiol Gastrointest Liver Physiol 2001;280:G669–G677.
Q
Qi C, Pekala PH. Tumor necrosis factor-alpha-induced insulin resistance in adipocytes. Proc
Soc Exp Biol Med 2000;223:128 –135.
Qiao L, Goldberg JL, Russell JC, Sun XL. Identification of enhanced serine kinase activity in
insulin resistance. J Biol Chem 1999;274:10625-10632.
R
Rahbar S. An abnormal hemoglobin in reed cells of diabetics. Clin Chim Acta 1968;22:296–
8.
Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung
inflammation: therapeutic approaches. Free Radic Biol Med 2000;28:1405-20.
Rambod M, Broumand B. Glycosylated hemoglobin, glycemic control, and mortality in
hemodialzed diabetic patients. Kidney Int 2007;71:1078.
Rana SVS, Allen T, Singh R. Inevitable glutathione, then and now. Indian J Exp Biol 2002;
40: 706-716.
Raught B, Gingras AC, Sonenberg N. The target of rapamycin (TOR) proteins. Proc Natl
Acad Sci U S A 2001;98:7037–44.
290
Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, Niebauer J,
Hooper J, Volk HD, Coats AJ, Anker SD. Plasma cytokine parameters and mortality in
patients with chronic heart failure. Circulation 2000;102:3060–3067.
Reaich D, Channon SM, Scrimgeour CM, Daley SE, Wilkinson R, Goodship THJ. Correction
of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am
J Physiol 1993;265:E230-E235.
Reaven GM. Insulin resistance and its consequences: type 2 diabetes mellitus and coronary
heart disease. In Diabetes Mellitus: A Fundamental and Clinical Text. LeRoith D, Taylor SI,
Olefsky JM, Eds. Philadelphia,Lippincott Williams & Wilkins, 2000, p. 604–615.
Reibel DK, Shaffer JE, Kocsis JJ, Neely JR. Changes in taurine content in heart and other
organs of diabetic rats. J Mol Cell Cardiol 1979; 11: 827–830.
Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression.
Kidney Int 1997;51:2-15.
Remuzzi G, Bemuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J
Med 1998;339:1448–1456.
Renier G. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), a relevant target
for diabetic vasculopathy? Cardiovasc Hematol Disord Drug Targets 2008;8:203-11.
Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for
carbonyl assay. Methods Enzymol 1994;233:357–63.
Richard MJ, Arnaud J, Jurkovitz C, Hachache T, Meftachi H, Laporte F, Foret M, Favier A,
Corolonnier D. Trace elements and lipid peroxidation abnormalities in patients with chronic
renal failure. Nephron 1991;57:10–15.
Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and
the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973–9.
Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment
in the primary prevention of cardiovascular disease. Circulation 2001;103:1813–1818.
Ridker PM, Rifai N, Stampfer MJ, Hennekens. Plasma concentration of interleukin-6 and the
risk of future myocardial infarction among apparently healthy men. Circulation
2000;101:1767– 1772.
Rigalleau V, Combe C, Blanchtier V, Aubertin J, Apacicio M, Gin H. Low protein diet in
uremia: Effects of glucose metabolism and energy production rate. Kidney Int 1997;51:1222-
1227.
Roden M, Shulman GI. Applications of NMR spectroscopy to study muscle glycogen
metabolism in muscle. Annu Rev Med 1999;50:277–290.
291
Rodriguez-Garcia J, Requena JR, Rodriguez-Segade R. Increased concentrations of serum
pentosidine in rheumatoid arthritis. Clin Chem 1998;44:250-255.
Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 2000;85:9-21.
Rosenzweig T, Braiman L, Bak A, Alt A, Kuroki T, Sampson SR. Differential effects of
tumor necrosis factor-alpha on protein kinase C isoforms alpha and delta mediate inhibition
of insulin receptor signaling. Diabetes 2002;51:1921–1930.
Rothwarf DM, Zandi E, Natoli G, Karin M. IKKgamma is an essential regulatory subunit of
the IkappaB kinase complex. Nature 1998;395:297–300.
Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3–L1
adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells
from insulin-resistant subjects. J Biol Chem 2030;278:45777–45784.
Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium:
Biochemical roles as a component of glutathione peroxidase. Science 1973; 179: 588-590.
Roxborough HE, Mercer C, McMaster D, Young IS. Plasma glutathione peroxidase activity
is reduced in haemodialysis patients. Nephron 1999;81:278–283.
Ruan H, Miles PD, Ladd CM, Ross K, Golub TR, Olefsky JM, Lodish HF. Profiling gene
transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-
alpha: implications for insulin resistance. Diabetes 2002;51:3176-3188.
Rudich A, Kozlovsky N, Potashnik R, Bashan N. Oxidant stress reduces insulin
responsiveness in 3T3-L1 adipocytes. Am J Physiol 1997;272:E935–40.
Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N. Prolonged oxidative stress
impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 1998;47:1562–
1569.
Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G. Urinary protein excretion rate is
the best independent predictor of ESRF in non-diabetic proteinuria chronic nephropathies.
“Gruppo Italiano di Studi Epidemiologici in Nefrologia” (GISEN). Kidney Int 1998;53:1209-
1216.
S Saad MJA, Araki E, Miralpeix M, Rothenberg PL, White MF, Kohn CR. Regulation of
insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin
Invest 1992;90:1839-1849.
292
Sabater J, Quereda C, Herrera I, Pascual J, Villafruela J, Ortuno J. Nonenzymatic
glycosylation of hemoglobin and total plasmatic proteins in end-stage renal failure. Am J
Nephrol 1991;11:37-43.
Sadaivudu B, Sasikala M, Sailaja V, Reddy SS. Serum malondialdehyde, insulin, glucose and
lipid profile in hypertension. Med Sci Res 1997; 25: 631–633.
Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP, Rice-Evans C. Polyphenolic
flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch
Biochem Biophys 1995;322:339-346.
Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, Barford D. Redox
regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate.
Nature 2003;423:769–773.
Salonen JT, Nyyssonen K, Tuomainen TP, et al. Increased risk of non-insulin dependent
diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men.
Br Med J 1995; 311: 1124–1127.
Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism.
Nature 2001;414:799-806.
Sathiyapriya V, Bobby Z, Vinod Kumar S, Selvaraj N, Parthibane V, Swapnil G. Evidence
for the role of lipid peroxides on glycation of hemoglobin and plasma proteins in non-diabetic
asthma patients. Clin Chim Acta 2006;366:299-303.
Sathiyapriya V, Selvaraj N, Nandeesha H, Bobby Z, Agrawal A, Pavithran P. Enhanced
glycation of hemoglobin and plasma proteins is associated with increased lipid peroxides
levels in non-diabetic hypertensive subjects. Arch Med Res 2007;38:822-826.
Sathiyapriya V, Selvaraj N, Nandeesha H, Bobby Z, Agrawal A, Sridhar MG, Pavithran P,
Rattina Dasse. Increased glycation of hemoglobin and plasma proteins in normotensive, non-
diabetic obese Indian subjects: putative role of lipid peroxides. Clin Chem Lab Med
2007;45:996-999.
Sasaki S, Yokozawa T, Cho EJ, Oowada S, Kim M. Protective role of gamma-aminobutyric
acid against chronic renal failure in rats. J Pharm Pharmacol 2006;58:1515-25.
Scanferla F, Landini S, Fracasso A, Righetto F, Scanferla F, Toffoletto P, Genchi R, Bazzato
G. Risk factors for the progression of diabetic nephropathy: Role of hyperlipidemia and its
correction. Acta Diabetol 1992;29:268-272.
Schmid E, El Benna J, Galter D, Klein G, Dr ge W. Redox priming of the insulin receptor β-
chain associated with altered tyrosine kinase activity and insulin responsiveness in the
absence of tyrosine autophosphorylation. FASEB J. 1998;12:863–870.
293
Schmitt TL, Hotz-Wagenblatt A, Klein H, Dr ge WJ. Interdependent regulation of insulin
receptor kinase activity by ADP and hydrogen peroxide. J Biol Chem 2005;280:3795–3801.
Schmitz A, Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent
diabetes. A 10-year follow up study of 503 patients. Diabet Med 1988;5:126-134.
Scholze A, Rinder C, Beige J, Riezler R, Zidek W, Tepel M. Acetylcysteine reduces plasma
homocysteine concentration and improves pulse pressure and endothelial function in patients
with end-stage renal failure. Circulation 2004;109:369-374.
Schwartz JC. The role of glycohemoglobin and other proteins in diabetes management.
Diabetes Rev 1995;3:269 –87.
Sechi LA, Catena C, Zingaro L, Melis A, De Marchi S. Abnormalities of glucose metabolism
in patients with early renal failure. Diabetes 2002;51:1226-1232.
Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance
in hepatocytes. Diabetes 2002;51:3391–3399.
Shah SV. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney
Dis 1989;35:1093-1106.
Shah OJ, Wang Z, Hunter T. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette
induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol
2004;14:1650-1656.
Shahidi F, Wanasundara PD. Phenolic antioxidants. Critical Reviews in Food Science and
Nutrion 1992;32:67-103.
Sharma K, Khosla PK, Tiwari HK, Sharma RK, Bajaj JS. Anti-insulin antibodies and
retinopathy in juvenile onset type-1 diabetes. Indian J Ophthalmol 1991;39:174–5.
Sheehan EW, Zematis MA. A constituent of Pterocarpus Marsupium, (-)-epicatechin, as a
potential antidiabetic agent. J Nat Prod 1983;46:232-234.
Shin MJ, Park E, Lee JH, Chung N. Relationship between insulin resistance and lipid
peroxidation and antioxidant vitamins in hypercholestrolemic patients. Ann Nutr Metab
2006;50:115–120.
Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM.
Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal
insufficiency. Circulation 2003;107:87–92.
Sies H, Sharov VS, Klotz LO, Briviba K. Glutathione peroxidase protects against
peroxynitrite-mediated oxidations: a new function for selenoproteins as peroxynitrite
reductase, J Biol Chem 1997;272:27812– 27817.
294
Sinha S, Perdomo G, Brown NF, Doherty RM. Fatty acids induced insulin resistance in L6
myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor
kappa B. J Biol Chem 2004;279:41294-41301.
Sit D, Kardioglu AK, Kayabasi H, Yilmaz ME. The prevalence of insulin resistance in
nondiabetic nonobese patients with chronic kidney disease. Adv Ther 2006;23:988-998.
Slatter AD, Murray M, Bailey AJ. Formation of a dihydropyridine derivative as a potential
cross-link from malondialdehyde in physiological systems. FEBS Lett 1998;421:180-184.
Slatter DA, Bolton CH, Bailey AJ. The importance of lipid-derived malondialdehyde in
diabetes mellitus. Diabetologia 2000;43:550-557.
Smith WGJ, Holden M, Benton M, Brown CB. Carbamylated haemoglobin in chronic renal
failure. Clin Chim Acta 1988;178:297-304.
Stachowska E, Wesolowska T, Olszewska M, Safranow K, Millo B, Domanski L,
Jakubowska K, Ciechanowski K, Chlubek D. Elements of Mediterranean diet improves
oxidative status in blood of kidney graft recipients. Br J Nutr 2005;93:345–352.
Stadtman ER. Metal ion in catalyzed oxidation of proteins: Biochemical mechanism and
biological consequences. Free Radic Biol Med 1990; 9: 315-325.
Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL. Beyond cholesterol:
modifications of low-density lipoprotein that increases its atherogenicity. N Eng J Med 1989;
320: 915-924.
Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin mediated skeletal
muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric
oxide release. J Clin Invest 1994; 94:1172–1179.
Stenvinkel P, Ottosson-Seeberger A, Alvestrand A. Renal hemodynamics and sodium
handling in moderate renal insufficiency: The role of insulin resistance and dyslipidemia. J
Am Soc Nephrol 1994;5:1751-1760.
Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T.
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal
failure. Kidney Int 1999;55:1899-1911.
Stenvinkel P, Alvestrand P. Inflammation in end-stage renal disease: Sources, consequences
and therapy. Semin Dial 2002;15:330–338.
Stenvinkel P, Barany P, Heimbürger O, Pecoits-Filho R, Lindholm B. Mortality, malnutrition
malnutrition and atherosclerosis in end-stage renal disease: What is the role of interleukin-6?
Kidney Int 2002; 61:S103–S108.
295
Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimbürger
O, Cederholm T, Girndt M. IL-10, IL-6, and TNF-a: Central factors in the altered cytokine
network of uremia—The good, the bad, and the ugly. Kidney Int 2005;67:1216–1233.
Stolba P, Hatle K, Krnakova A, Streda M, Starka L. Effects of ascorbicacid on nonenzymatic
glycation of serum proteins in vitro and in vivo. Diabetologia 1987;30:585A
Sommerburg O, Grune T, Ehrich JHH, Siems WG. Adaptation of glutathione peroxidase
activity to oxidative tress occurs in children but not in adult patients with end-stage renal
failure undergoing hemodialysis. Clin Nephrol 2002;58:S31–S36.
Sundaram RC, Selvaraj N, Vijayan G, Bobby Z, Hamide A, Rattina Dasse N. Increased
plasma malondialdehyde and fructosamine in iron deficiency anemia: effect of treatment.
Biomed Pharmacother 2007;61:682-685.
Suematsu M, Suzuki H, Delano A, Schmid-Schonbein GW. The inflammatory aspect of the
microcirculation in hypertension; oxidative stress, leukocytes/endothelial interaction,
apoptosis. Microcirculation 2002;9:259-276.
Sugarman BJ, Aggarwal BB, Hass PE, et al. Recombinant human tumor necrosis factor-
alpha: Effects on proliferation of normal and transformed cells in vitro. Science
1985;230:943–945.
Sutherland BA, Rahman RM, Appleton I. Mechanisms of action of green tea catechins, with
a focus on ischemia-induced neurodegeneration. J Nutr Biohcem 2006;17:291-306.
Suyama K, Kabuyama Y, Suzuki S, Kawasaki Y, Suzuki J, Suzuki H, Homma Y. Induction
of transcription factor AP-2 by cytokines and prostaglandins in cultured mesangial cells. Am
J Nephrol 2001;21,307–314.
Svenungsson E, Feig Z, Jensen-Urstad K, de Faire U, Hamsten A, Frostegard J. TNF-alpha:
A link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular
disease. Lupus 2003;12:454–461.
T
Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T.
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130.
Cell 1989;58:573–581.
Takahashi T, Kubita M, Nakamura T, Ebihara I, Koide H. Interleukin-6 gene expression in
peripheral mononuclear cells from patients undergoing hemodialysis or continuous
ambulatory peritoneal dialysis. Ren Fail 2000;22:345–354.
296
Talior I, Tennenbaum T, Kuroki T, Eldar-Finkelman H. Increased risk of obesity resulting
from the interaction between high energy intake and the Trp64Arg polymorphism of the
beta3-adrenergic receptor gene in healthy Japanese men. J Epidemiol 2005;15:203-10.
Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H, Fukiyama K.Significant
association between the progression of coronary artery calcification and dyslipidemia in
patients on chronic hemodialysis. Am J Kidney Dis 2001;38:64-9.
Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A: Change in the ratio
of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic
inflammatory response syndrome. Crit Care Med 1999;27:1262–1264.
Tanti JF, Gremeaux T, Obberghen E, Marchand-Brustel Y, Serine/threonine phosphorylation
of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem
1994;269:6051– 6057.
Tas S, Dirican M, Sarandol E, Serdar Z. The effect of taurine supplementation on oxidative
stress in experimental hypothyroidism. Cell Biochem Funct 2006;24:153-158.
Taylor SI, Samuels B, Roth J, et al. Decreased insulin binding in cultured lymphocytes from
two patients with extreme insulin resistance. J Clin Endocrinol Metab 1982;54:919–30.
Tepel M, van der Giet M, Statz M, Jankowski J, Zidek W. The antioxidant acetylcysteine
reduces cardiovascular events in patients with end-stage renal failure: a controlled trial.
Circulation 2003;107:992-995.
Teruel T, Hernandez R, Lorenzo M. Ceramide mediates insulin resistance by tumor necrosis
factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state.
Diabetes 2001;50:2563–2571.
Tesio F, Cecchin E, De Marchi S, Quaia P. Glycosylated or carbamylated hemoglobin in
uremia? N Engl J Med 1982;306:1053.
Testa R, Testa I, Manfrini S, Bonfigli AR, Piantanelli I, Marra M, Pieri C. Glycosylated
hemoglobin and fructosamines: does their determination really reflect the glycemic control in
diabetic patients. Life Sci 1996;59:43-49.
Thornalley PJ. Advanced glycation and the development of diabetic complications. Unifying
the involvement of glucose, methylglyoxal and oxidative stress. Endocrinol Metab
1996;3:149–66.
Timoshanko JR, Sedgwick JD, Holdsworth SR, Tipping PG. Intrinsic renal cells are the
major source of tumor necrosis factor contributing to renal injury in murine crescentic
glomerulonephritis. J Am Soc Nephrol 2003;14:1785–1793.
297
Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor α promotes in vitro
calcification of vascular cells via the cAMP pathway. Circulation 2000;102:2636–2642.
Tipping PG, Leong TW, Holdsworth SR. Tumor necrosis factor production by glomerular
macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. Lab
Invest 1991;65:272–279.
Tirosh A, Potashnik R, Bashan N, Rudich A. Oxidative stress disrupts insulin-induced
cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in
3T3-L1 adipocytes: A putative cellular mechanism for impaired protein kinase B activation
and GLUT4 translocation. J Biol Chem 1999;274:10595–10602.
Tirosh A, Rudich A, Potashnik R, Bashan N. Oxidative stress impairs insulin but not platelet-
derived growth factor signalling in 3T3-L1 adipocytes. Biochem J 2001;355:757–763.
Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide
gels to nitrocellulose sheets. Pro Natl Acad Sci 1975; 16, 4350-4354.
Trachtman H, Futterweit S, Maesaka J, Ma C, Valderrama E, Fuchs A, Tarectecan AA, Rao
PS, Sturman JA, Boles TH,. Taurine ameliorates chronic streptozotocin-induced diabetic
nephropathy in rats. Am J Physiol 1995;269:F429-38.
Trevisan M, Browne R, Ram M, Muti P, Freudenheim J, Carosella M, Armstrong D.
Correlates of markers of oxidative stress in the general population. Am J Epidemiol
2001;154:348-356.
Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M, Hotamisligil GS. Functional in vivo
interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. PNAS 2006;
103: 10741–6.
Turrens JF, Boveris A. Generation of superoxide anions by the NADH dehydrogenase of
bovine heart mitochondria. Biochem J 1980;191:421–427.
U
Um SH, Frogerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini
PR, Kozma SC, Aumerx J, Thomas G. Absence of S6K1 protects against age- and diet-
induced obesity while enhancing insulin sensitivity. Nature 2004;431:200-205.
Uma K, Rondeau E, Jean-Daniel S, Michael AF, Tsilibary EC. Alterations in human
glomerular epithelial cells interacting with non-enzymatically glycosyalted matrix. J Biol
Chem 1997;44:27966– 70.
298
Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced
insulin resistance in mice lacking TNF-alpha function. Nature 1997;389:610–614.
V
van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frolich M. Anti-
inflammatory cytokine profile and mortality in febrile patients. Lancet 1998;351:950–953.
Vareesangthip K, Tong P, Wilkinson R, Thomas TH. Insulin resistance and adult polycystic
kidney disease. Kidney Int 1997;52:503-508.
Vaziri ND, Ni Z, Oveisi F, Liang K, Pandian R. Enhanced nitric oxide inactivation and
protein nitration by reactive oxygen species in renal insufficiency. Hypertension
2002;39:135-141.
Vaziri ND. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential
consequences. Am J Physiol Renal Physiol. 2006;290:F262-72.
Verma S, Li SH, Badiwala MV, Weisel RD, Fedak PW, Li RK, Dhillon B, Mickle DA.
Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-
reactive protein. Circulation 2002;105:1890–1896.
Venkatesan A, Hemalatha A, Bobby Z, Selvaraj N, Sathiyapriya V. Nonenzymatic glycation
of plasma proteins in smokers. Indian J Physiol Pharmacol 2006;50:403-408.
Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I.. Demonstration that C-reactive
protein decreases eNOS expression and bioactivity in human aortic endothelial cells.
Circulation 2002;106:1439–1441.
Vijayalingam S, Parthiban A, Shanmugasundaram KR, Mohan V. Abnormal antioxidant
status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabet Med
1996;13: 715–719.
Vijayan G, Sundaram RC, Bobby Z, Hamide A, Selvaraj N, Rattina Dasse N. Increased
plasma malondialdehyde and fructosamine in anemic H. pylori infected patients: effect of
treatment. World J Gastroenterol 2007;13:796-800.
Vina JR, Saez GT, Vina J. The physiological fuctions of glutathione. In: CRC Hand Book of
Free Radicals and Antioxidants in Biomedicine. Miquel J, Quantaniha AT, Weber H (eds),
CRC Press Inc., Boca Raton, 1989; p 121-132.
Vinson JA, Teufel K, Wu N. Green and black teas inhibit atherosclerosis by lipid,
antioxidant, and fibrinolytic mechanisms. J Agric Food Chem 2004;52:3661-5.
299
Vinayaga Moorthi R, Bobby Z, Selvaraj N, Sridhar MG. Vitamin E protects the insulin
sensitivity and redox balance in rat L6 muscle cells exposed to oxidative stress. Clin Chim
Acta 2006;367:132–136.
Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tatranni PA. High white blood
cell count is associated with a worsening of insulin sensitivity and predicts the development
of type 2 diabetes. Diabetes 2002;51:455–461.
W
Wagner BA, Buettner GR, Burns CP. Free-radical mediated lipid peroxidation in cells:
oxidizability is a function of cell lipid bis-allylic hydrogen content. Biochemistry
1994;33:4449–4453.
Walker WG. Relation of lipid abnormalities to progression of renal damage in essential
hypertension, insulin-dependent and non-insulin-dependent diabetes mellitus. Miner
Electrolyte Metab 1993;19:137-143.
Waltner-Law ME, Wang XL, Law BK, Hall RK, Nawano M, Granner DK. Epigallocatechin
gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem
2002;277:34933-40.
Wang CC, Goalstone ML, Draznin B. Molecular mechanisms of insulin resistance that
impact cardiovascular biology. Diabetes 2004;53:2735–40.
Wang X, Peesapati SK, Renedo MF, Moktan S. Hemoglobin A1C levels in non-diabetic
patients with end-stage renal disease (ESRD) receiving hemodialysis. J Endocrinol Invest
2004;27:733-735.
Wanner C, Metzger T. C-reactive protein a marker for all-cause and cardiovascular mortality
in haemodialysis patients. Nephrol Dial Transplant 2002;17:29-32.
Weigert C, Hennige AM, Tasja Brischmann T, Moeschel K, Myriam S, Rainer L. The
phosphorylation of Ser318 of insulin receptor substrate- 1 is not per se inhibitory in skeletal
muscle cells but is necessary to trigger the attenuation of the Insulin-stimulated signal. J
Biol Chem 2005;280, 37393–37399.
Wells-Knecht KJ, Brinkmann E, Wells-Knecht MC, Litchfield JE, Ahmed MU, Reddy S,
Zyzak DV, Thorpe SR, Baynes JW. New biomarker of Maillard reaction damage to proteins.
Nephrol Dial Transplant 1996;11:41-47.
300
Wendel A. Glutathione peroxidase. Methods Enzymol 1981; 77:325–333.
West IC. Radicals and oxidative stress in diabetes. Diabet Med 17:171–180, 2000.
Westervelt FB. Insulin effect in uremia. J Lab Clin Med 1969;74:79-84.
White MF. Insulin signalling in health and disease. Science 2003;302:1710-1711.
Wild S, Sireee R, Roglic G, King H, Green A. Global prevalence of diabetes. Estimates for
the year 2000 and projection for 2030. Diabetes Care 2004;27:1047–1053.
Williams ME, Lacson E Jr, Ofsthun N, Lazarus JM. Hemodialysis type 1 and type II diabetic
patients in the US: characteristics, glycemic control, and survival. Kidney Int 2006;70:1503-
1509.
Wilkinson KD. Signal transduction: aspirin, ubiquitin and cancer. Nature 2003;424:738–739.
Wiseman SA, Balentine DA, Frei B. Antioxidants in tea. Critical Reviews in Food Science
and Nutrition 1997;37:705-718.
Wolf G, Butzmann U, Wenzel UO. The rennin-angiotensin system and progression of renal
disease: from hemodynamics to cell biology. Nephron Physiol 2003;93:P3-P13.
Wolff SP, Dean RT. Glucose autoxidation and protein modification and protein modification:
the potential role of autoxidative glycosylation in diabetes. Biochem J 1988;256: 205– 12.
Wright Jr E, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of
fasting and postprandial glycaemia. Int J Clin Pract 2006;60:308–314.
Wu LY, Juan CC, Hwang LS, Hsu YP, Ho PH, Ho LT. Green tea supplementation
ameliorates insulin resistance and increase glucose transport IV content in a fructose-fed rat
model. Eur J Nutr 2004;43:116-124.
Wu CC, Hsu MC, Hsieh CW, Lin JB, Lai PH, Wung BS. Upregulation of heme oxygenase-1
by epigallocatechin-3 gallate via the phosphatidylinositol 3 kinase/Akt and ERK pathways.
Life Sci 2006;78:2889-2897.
X
Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and
JNK-p38 MAP kinases on apoptosis. Science 1995;270, 1326–1331.
Xu L, Badr MZ. Enhanced potential for oxidative stress in hyperinsulinemic rats: imbalance
between hepatic peroxisomal hydrogen peroxide production and decomposition due to
hyperinsulinemia. Horm Metab Res 1999;31:278–282.
301
Y
Yagi K. Assay for blood plasma or serum lipid peroxides. Methods Enzymol 1984;105:28–
31.
Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ, Israel
A. Complementation cloning of NEMO, a component of the IkappaB kinase complex
essential for NF-kappaB activation. Cell 1998;93:1231–1240.
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K,
Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML,
Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel
P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated
with both lipoatrophy and obesity. Nat Med 2001;7:941–946.
Yeun JY, Kaysen GA. C-reactive protein, oxidative stress, homocysteine, and troponin as
inflammatory and metabolic predictors of atherosclerosis in ESRD. Curr opin Nephrol
Hypertens 2000;9:621-630.
Yeung JH. Effects of glycerol-induced acute renal failure on tissue glutathione and
glutathione-dependent enzymes in the rat. Methods Find Exp Clin Pharmacol 1991;13:23-8.
Yue DK, McLennan S, Church DB, Turtle JR. The measurement of glycosylated hemoglobin
in man and animals by aminophenylboronic acid affinity chromatography. Diabetes
1982;31:701– 5.
Yildirim Z, Kilic N, Ozer C, Babul A, Take G, Erdogan D. Effects of taurine in cellular
responses to oxidative stress in young and middle-aged rat liver. Ann N Y Acad Sci 2007;
1100:553-561.
Yokozawa T, Zheng PD, Oura H, Koizumi F. Animal model of adenine-induced chronic
renal failure in rats. Nephron 1986;44:230-234.
Yokozawa T, Him HW,Kim HY, Tanaka T, Sugino H, Okubo T, Chu D-C, Juneja LJ. Amla
(Emblica officinalis Gaertn.) Attenuates Age-Related Renal Dysfunction by Oxidative Stress.
J Agric Food Chem 2007,55:7744–7752.
Youngren JF, Paik Bernard JR, Impaired insulin receptor autophosphorylation is an early
defect in fat-fed, insulin resistant rats. Am J Physiol 2001;91, 2240-2247.
302
Yoshimura S, Suemizu H, Nomoto Y, Sakai H, Katsuoka Y, Kawamura N, Moriuchi T.
Plasma glutathione peroxidase deficiency caused by renal dysfunction. Nephron 1996;73:
207–211.
Yoon JW, Pahl MV, Vaziri ND. Spontaneous leukocyte activation and oxygen-free radical
generation in end-stage renal disease. Kidney Int 2007;71:167-172.
Yu BP. Cellular defenses against damage from reactive oxygen species. Physiological
Reviews 1994; 74: 139- 162.
Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE. Reversal of
obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKK- β.
Science 2001;293:1673-1677.
Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects:
associations with obesity, insulin resistance, and endothelial dysfunction. Arterioscler
Thromb Vasc Biol 1999;19:972–978.
Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and
coronary heart disease: Is interleukin-6 the link? Atherosclerosis 2000;148:209–214.
Z
Zachara BA, Adamowicz A, Trafikowska U, Pilecki A. Decreased plasma glutathione
peroxidase activity in uremic patients. Nephron 2000;84: 278–279.
Zachara BA, Trafikowska U, Adamowicz A, Nartowicz E, Manitius J. Selenium, glutathione
peroxidases, and some other parameters in blood of patients with chronic renal failure. J
Trace Elem Med Biol 2001;15:161–166.
Zachara BA, Koterska D, Manitius J, Sadowski L, Dziedziczko A, Salak A, Wasowicz W.
Selenium supplementation to patients with the end stage of chronic renal failure has no effect
on the increase of lowered plasma glutathione peroxidase activity. Biol Trace Elem Res
2004a;97: 15–30.
Zachara BA, Salak A, Koterska D, Manitius J, Wasowicz W. Selenium and glutathione
peroxidases in blood of patients with different stages of chronic renal failure. J Trace Elem
Med Biol 2004b;17:291–299.
Zachara BA, Wlodarczyk Z, Andruszkiewicz J, Gromadzinska J, Wasowicz W. Glutathione
and glutathione peroxidase activities in blood of patients in early stages following kidney
transplantation. Ren Fail 2005;27:751-5.
303
Zanetti M, Barazzoni R, Bosutti A, Stocca A, Grassi G, Guarnieri G. Vascular sources of
oxidative stress: implications for uremia-related cardiovascular disease. J Ren Nutr 2007
17:53-56.
Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IkappaB kinase complex
(IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB
phosphorylation and NF-kappaB activation. Cell 1997;91:243–252.
Zaveri NT. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer
applications.Life Sci. 2006;78:2073-80.
Zanetti M, Barazzoni R, Bosutti A, Stocca A, Grassi G, Guarnieri G. Vascular sources of
oxidative stress: implications for uremia-related cardiovascular disease. J Ren Nutr
2007;17:53-56.
Zanetti M, Barazzoni R, Guarnieri G. Inflammation and insulin resistance in uremia. J Ren
Nutr 2008;18:70-75.
Zhang B, saku K, Hirata K, Liu R, Tateishi K, Shiomi M, Arakawa K. Quantitative
characterization of insulin-glucose response in Watanabe heritable hyperlipidemic and
cholesterol-Fed rabbits and the effect of cliazapril. Metabolism 1994; 43: 360-366.
Zhou LZ, Johnson AP, Rando TA. NF kappa B and AP-1 mediate transcriptional responses to
oxidative stress in skeletal muscle cells. Free Radic Biol Med 2001;31:1405–1416.
Zhu CH, Huang Y, Oberley LW, Domann FE. A family of AP-2 proteins down-regulate
Manganese superoxide dismutase expression. J Biol Chem 2001;276:14407-14413.
Zimmer S, Pollard V, Marshall GD, Garafalo RP, Traber D, Prough D, Herndon DN. The
1996 Moyer Award. Effects of endotoxin on the Th1/Th2 response in humans. J Burns Care
Rehabil 1996;17:491–496.
Zuckerman SH, O’Neal L. Endotoxin and GM-CSF-mediated down-regulation of
macrophage ApoE secretion is inhibited by a TNF-specific monoclonal antibody. J Leukoc
Biol 1994;55:743–748.
Zwolinska D, Grzeszczak W, Kilis-Pstrucinska K, Szprynger K, Szczepanska M. Lipid
peroxidation and antioxidant enzymes in children with chronic renal failure. Pediatr Nephrol
2004;19:888–892.
304
List of papers publication
1. Selvaraj N, Bobby Z, Sathiyapriya V. Effect of lipid peroxides and antioxidants on
glycation of hemoglobin: An in vitro study on human erythrocytes. Clin Chim Acta 2006;
366: 190-5.
2. Sathiyapriya V, Bobby Z, Vinod Kumar S, Selvaraj N, Parthibane V, Swapnil Gupta.
Evidence for the role of lipid peroxides on glycation of hemoglobin and plasma proteins in
non-diabetic asthma patients. Clin Chim Acta 2006; 366: 299-303. (This paper contains as
part the in vitro study on the effect of H2O2 on glycation of hemoglobin)
3. Selvaraj N, Balamurugan R, Bobby Z, Sathiyapriya V. Increased glycated hemoglobin
level in non-diabetic nephrotic children is associated with oxidative stress. Indian J Physiol
Pharmacol 2007;51:153-159. (This paper contains as part the in vitro study on the effect of
GSH on glycation of hemoglobin)
4. Selvaraj N, Bobby Z, Sridhar MG. Oxidative stress: Does it play a role in the genesis of
early glycated proteins? Medical Hypothesis 2008;70:265-268.
5. Selvaraj N, Bobby Z, Sridhar MG. Increased glycation of hemoglobin in chronic renal
failure: Potential role of oxidative stress. Achieves of Medical Research 2008;39:277-284.
published erratum appears in Archieves of Medical Research 2008;39:466.